{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Retinoblastma", "circular RNA", "exosome", "microRNA", "non-coding RNAs"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36619866", "DateRevised": {"Year": "2023", "Month": "01", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "23"}], "Language": ["eng"], "ELocationID": ["1065837", "10.3389/fcell.2022.1065837"], "Journal": {"ISSN": "2296-634X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in cell and developmental biology", "ISOAbbreviation": "Front Cell Dev Biol"}, "ArticleTitle": "Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.", "Pagination": {"StartPage": "1065837", "MedlinePgn": "1065837"}, "Abstract": {"AbstractText": ["Retinoblastoma (RB) is a rare aggressive intraocular malignancy of childhood that has the potential to affect vision, and can even be fatal in some children. While the tumor can be controlled efficiently at early stages, metastatic tumors lead to high mortality. Non-coding RNAs (ncRNAs) are implicated in a number of physiological cellular process, including differentiation, proliferation, migration, and invasion, The deregulation of ncRNAs is correlated with several diseases, particularly cancer. ncRNAs are categorized into two main groups based on their length, i.e. short and long ncRNAs. Moreover, ncRNA deregulation has been demonstrated to play a role in the pathogenesis and development of RB. Several ncRNAs, such as miR-491-3p, miR-613,and SUSD2 have been found to act as tumor suppressor genes in RB, but other ncRNAs, such as circ-E2F3, NEAT1, and TUG1 act as tumor promoter genes. Understanding the regulatory mechanisms of ncRNAs can provide new opportunities for RB therapy. In the present review, we discuss the functional roles of the most important ncRNAs in RB, their interaction with the genes responsible for RB initiation and progression, and possible future clinical applications as diagnostic and prognostic tools or as therapeutic targets."], "CopyrightInformation": "Copyright \u00a9 2022 Ahangar Davoodi, Najafi, Naderi Ghale-Noie, Piranviseh, Mollazadeh, Ahmadi Asouri, Asemi, Morshedi, Tamehri Zadeh, Hamblin, Sheida and Mirzaei."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Eye Research Center, Rassoul Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Ahangar Davoodi", "ForeName": "Nasrin", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Najafi", "ForeName": "Sajad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Naderi Ghale-Noie", "ForeName": "Zari", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Piranviseh", "ForeName": "Ashkan", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Ahmadi Asouri", "ForeName": "Sahar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Asemi", "ForeName": "Zatollah", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran."}, {"Identifier": [], "Affiliation": "School of Medicine, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Morshedi", "ForeName": "Mohammadamin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Tamehri Zadeh", "ForeName": "Seyed Saeed", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa."}], "LastName": "Hamblin", "ForeName": "Michael R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran."}, {"Identifier": [], "Affiliation": "School of Medicine, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Sheida", "ForeName": "Amirhossein", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Mirzaei", "ForeName": "Hamed", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Cell Dev Biol", "NlmUniqueID": "101630250", "ISSNLinking": "2296-634X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abe H., Kamai T., Hayashi K., Anzai N., Shirataki H., Mizuno T., et al. (2014). The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells. BMC cancer 14 (1), 412\u201312. 10.1186/1471-2407-14-412", "ArticleIdList": ["10.1186/1471-2407-14-412", "PMC4081468", "24908363"]}, {"Citation": "Aerts I., Lumbroso-Le Rouic L., Gauthier-Villars M., Brisse H., Doz F. (2015). Retinoblastoma update. Arch. Pediatr. 23 (1), 112\u2013116. 10.1016/j.arcped.2015.09.025", "ArticleIdList": ["10.1016/j.arcped.2015.09.025", "26679524"]}, {"Citation": "Ardoin S. P., Pisetsky D. S. (2008). The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. Mod. Rheumatol. 18 (4), 319\u2013326. 10.1007/s10165-008-0054-z", "ArticleIdList": ["10.1007/s10165-008-0054-z", "PMC2516192", "18418695"]}, {"Citation": "Asnaghi L., White D. T., Key N., Choi J., Mahale A., Alkatan H., et al. (2019). ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma. Oncogene 38 (12), 2056\u20132075. 10.1038/s41388-018-0543-2", "ArticleIdList": ["10.1038/s41388-018-0543-2", "PMC6430693", "30401983"]}, {"Citation": "Bahn J. H., Zhang Q., Li F., Chan T-M., Lin X., Kim Y., et al. (2015). The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin. Chem. 61 (1), 221\u2013230. 10.1373/clinchem.2014.230433", "ArticleIdList": ["10.1373/clinchem.2014.230433", "PMC4332885", "25376581"]}, {"Citation": "Bai S., Tian B., Li A., Yao Q., Zhang G., Li F. (2016). MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma. Eye Lond. Engl. 30 (12), 1630\u20131638. 10.1038/eye.2016.189", "ArticleIdList": ["10.1038/eye.2016.189", "PMC5177757", "27518550"]}, {"Citation": "Bhattacharya R., SenBanerjee S., Lin Z., Mir S., Hamik A., Wang P., et al. (2005). Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J. Biol. Chem. 280 (32), 28848\u201328851. 10.1074/jbc.C500200200", "ArticleIdList": ["10.1074/jbc.C500200200", "15980434"]}, {"Citation": "Bianchi M. E. (2009). HMGB1 loves company. J. Leukoc. Biol. 86 (3), 573\u2013576. 10.1189/jlb.1008585", "ArticleIdList": ["10.1189/jlb.1008585", "19414536"]}, {"Citation": "Bishop J. O., Madson E. C. (1975). Retinoblastoma. Review of the current status. Surv. Ophthalmol. 19 (6), 342\u2013366.", "ArticleIdList": ["1145423"]}, {"Citation": "Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M. E., et al. (1998). High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell. Biol. 18 (8), 4471\u20134487. 10.1128/mcb.18.8.4471", "ArticleIdList": ["10.1128/mcb.18.8.4471", "PMC109033", "9671457"]}, {"Citation": "Boyiadzis M., Whiteside T. (2017). The emerging roles of tumor-derived exosomes in hematological malignancies. Leukemia 31 (6), 1259\u20131268. 10.1038/leu.2017.91", "ArticleIdList": ["10.1038/leu.2017.91", "28321122"]}, {"Citation": "Busch M., Miroschnikov N., Dankert J. T., Wieseh\u00f6fer M., Metz K., Stephan H., et al. (2021). Impact of RAR\u03b1 and miR-138 on retinoblastoma etoposide resistance. Tumour Biol. 43 (1), 11\u201326. 10.3233/TUB-200072", "ArticleIdList": ["10.3233/TUB-200072", "33935126"]}, {"Citation": "Cao L., Peng B., Yao L., Zhang X., Sun K., Yang X., et al. (2010). The ancient function of RB-E2F pathway: Insights from its evolutionary history. Biol. Direct 5 (1), 55\u201321. 10.1186/1745-6150-5-55", "ArticleIdList": ["10.1186/1745-6150-5-55", "PMC3224931", "20849664"]}, {"Citation": "Carvalho I. N., Reis A. H., Dos Santos A. C., Vargas F. R. (2017). A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastoma. Cancer Biomark. 18 (3), 313\u2013317. 10.3233/CBM-160248", "ArticleIdList": ["10.3233/CBM-160248", "28106538"]}, {"Citation": "Chai Y., Xiao J., Zhang S., Du Y., Luo Z., Zhou X., et al. (2018). High-mobility group protein B1 silencing promotes susceptibility of retinoblastoma cells to chemotherapeutic drugs through downregulating nuclear factor-\u03baB. Int. J. Mol. Med. 41 (3), 1651\u20131658. 10.3892/ijmm.2018.3379", "ArticleIdList": ["10.3892/ijmm.2018.3379", "29328447"]}, {"Citation": "Chan M. W., Huang Y. W., Hartman-Frey C., Kuo C. T., Deatherage D., Qin H., et al. (2008). Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. Neoplasia (New York, NY) 10 (9), 908\u2013919. 10.1593/neo.08540", "ArticleIdList": ["10.1593/neo.08540", "PMC2517635", "18714391"]}, {"Citation": "Che X., Qian Y., Li D. (2018). Suppression of disheveled-axin domain containing 1 (DIXDC1) by MicroRNA-186 inhibits the proliferation and invasion of retinoblastoma cells. J. Mol. Neurosci. 64 (2), 252\u2013261. 10.1007/s12031-017-1017-7", "ArticleIdList": ["10.1007/s12031-017-1017-7", "29264763"]}, {"Citation": "Chen G., Huang A. C., Zhang W., Zhang G., Wu M., Xu W., et al. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560 (7718), 382\u2013386. 10.1038/s41586-018-0392-8", "ArticleIdList": ["10.1038/s41586-018-0392-8", "PMC6095740", "30089911"]}, {"Citation": "Chen K., Hou Y., Liao R., Li Y., Yang H., Gong J. (2021). LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1. Oncogene 40 (18), 3217\u20133230. 10.1038/s41388-021-01671-2", "ArticleIdList": ["10.1038/s41388-021-01671-2", "33824472"]}, {"Citation": "Chen L-L. (2016). The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol. 17 (4), 205\u2013211. 10.1038/nrm.2015.32", "ArticleIdList": ["10.1038/nrm.2015.32", "26908011"]}, {"Citation": "Chen N. N., Chao D. L., Li X. G. (2020). Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell biochem. Funct. 38 (8), 1036\u20131046. 10.1002/cbf.3535", "ArticleIdList": ["10.1002/cbf.3535", "32266733"]}, {"Citation": "Chen S., Chen X., Luo Q., Liu X., Wang X., Cui Z., et al. (2021). Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Cell Death Dis. 12 (7), 695. 10.1038/s41419-021-03986-0", "ArticleIdList": ["10.1038/s41419-021-03986-0", "PMC8277798", "34257272"]}, {"Citation": "Chen S., Chen X., Qiu J., Chen P., Han X., Wu Y., et al. (2021). Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment. Oncol. Rep. 45 (1), 278\u2013290. 10.3892/or.2020.7858", "ArticleIdList": ["10.3892/or.2020.7858", "PMC7716702", "33416154"]}, {"Citation": "Chen Y., Lu B., Liu L., Pan X., Jiang C., Xu H. (2021). Long non-coding RNA PROX1-AS1 knockdown upregulates microRNA-519d-3p to promote chemosensitivity of retinoblastoma cells via targeting SOX2. Cell Cycle 20 (20), 2149\u20132159. 10.1080/15384101.2021.1971352", "ArticleIdList": ["10.1080/15384101.2021.1971352", "PMC8565814", "34583623"]}, {"Citation": "Cheng Y., Chang Q., Zheng B., Xu J., Li H., Wang R. (2019). LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101. Eur. J. Pharmacol. 843, 210\u2013216. 10.1016/j.ejphar.2018.11.028", "ArticleIdList": ["10.1016/j.ejphar.2018.11.028", "30472203"]}, {"Citation": "Cheng Y., Wang X., Wang P., Li T., Hu F., Liu Q., et al. (2016). SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer. Tumour Biol. 37 (7), 9919\u20139930. 10.1007/s13277-015-4734-y", "ArticleIdList": ["10.1007/s13277-015-4734-y", "26815503"]}, {"Citation": "Colucci-D\u2019Amato L., Speranza L., Volpicelli F. (2020). Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int. J. Mol. Sci. 21 (20), 7777. 10.3390/ijms21207777", "ArticleIdList": ["10.3390/ijms21207777", "PMC7589016", "33096634"]}, {"Citation": "Correa-Acosta A., Gonz\u00e1lez-Alviar M. E., Gaviria-Bravo M. L. (2018). Retinoblastoma and optic nerve enhancement in a brain magnetic resonance scan: Is it always a metastasis? Arch. Soc. Esp. Oftalmol. 93 (5), 251\u2013254. 10.1016/j.oftal.2017.10.010", "ArticleIdList": ["10.1016/j.oftal.2017.10.010", "29277434"]}, {"Citation": "Crews F. T., Qin L., Sheedy D., Vetreno R. P., Zou J. (2013). High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence. Biol. Psychiatry 73 (7), 602\u2013612. 10.1016/j.biopsych.2012.09.030", "ArticleIdList": ["10.1016/j.biopsych.2012.09.030", "PMC3602398", "23206318"]}, {"Citation": "Cui X., Liang T., Ji X., Shao Y., Zhao P., Li X. (004882022). LINC00488 induces tumorigenicity in retinoblastoma by regulating microRNA-30a-5p/EPHB2 Axis. Ocul. Immunol. Inflamm., 1\u20139. 10.1080/09273948.2022.2037659", "ArticleIdList": ["10.1080/09273948.2022.2037659", "35404750"]}, {"Citation": "Davidson C. E., Reese B. E., Billingsley M. L., Yun J. K. (2004). Stannin, a protein that localizes to the mitochondria and sensitizes NIH-3T3 cells to trimethyltin and dimethyltin toxicity. Mol. Pharmacol. 66 (4), 855\u2013863. 10.1124/mol.104.001719", "ArticleIdList": ["10.1124/mol.104.001719", "15269288"]}, {"Citation": "Delsin L. E. A., Salomao K. B., Pezuk J. A., Brassesco M. S. (2019). Expression profiles and prognostic value of miRNAs in retinoblastoma. J. Cancer Res. Clin. Oncol. 145 (1), 1\u201310. 10.1007/s00432-018-2773-7", "ArticleIdList": ["10.1007/s00432-018-2773-7", "30350021"]}, {"Citation": "Dimaras H., Corson T. W. (2019). Retinoblastoma, the visible CNS tumor: A review. J. Neurosci. Res. 97 (1), 29\u201344. 10.1002/jnr.24213", "ArticleIdList": ["10.1002/jnr.24213", "PMC6034991", "29314142"]}, {"Citation": "Dimova D. K., Dyson N. J. (2005). The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24 (17), 2810\u20132826. 10.1038/sj.onc.1208612", "ArticleIdList": ["10.1038/sj.onc.1208612", "15838517"]}, {"Citation": "Ding F., Jiang K., Sheng Y., Li C., Zhu H. (2020). LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Exp. Eye Res. 193, 107960. 10.1016/j.exer.2020.107960", "ArticleIdList": ["10.1016/j.exer.2020.107960", "32035086"]}, {"Citation": "Ding Y., Wu M., Liu J., Wu C., Huang R., Zhu R., et al. (2014). Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways. Exp. Eye Res. 122, 1\u20138. 10.1016/j.exer.2014.02.017", "ArticleIdList": ["10.1016/j.exer.2014.02.017", "24607444"]}, {"Citation": "Dokmanovic M., Marks P. A. (2005). Prospects: Histone deacetylase inhibitors. J. Cell. Biochem. 96 (2), 293\u2013304. 10.1002/jcb.20532", "ArticleIdList": ["10.1002/jcb.20532", "16088937"]}, {"Citation": "Dong Y., Wan G., Yan P., Qian C., Li F., Peng G. (2020). Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression. Aging 12 (9), 7729\u20137746. 10.18632/aging.103075", "ArticleIdList": ["10.18632/aging.103075", "PMC7244063", "32369777"]}, {"Citation": "Drula R., Braicu C., Harangus A., Nabavi S. M., Trif M., Slaby O., et al. (2020). Critical function of circular RNAs in lung cancer. Wiley Interdiscip. Rev. RNA 11 (5), e1592. 10.1002/wrna.1592", "ArticleIdList": ["10.1002/wrna.1592", "32180372"]}, {"Citation": "Du S., Wang S., Zhang F., Lv Y. (2020). SKP2, positively regulated by circ_ODC1/miR-422a axis, promotes the proliferation of retinoblastoma. J. Cell. Biochem. 121 (1), 322\u2013331. 10.1002/jcb.29177", "ArticleIdList": ["10.1002/jcb.29177", "31297892"]}, {"Citation": "Fang X., Wen J., Sun M., Yuan Y., Xu Q. (2019). CircRNAs and its relationship with gastric cancer. J. Cancer 10 (24), 6105\u20136113. 10.7150/jca.32927", "ArticleIdList": ["10.7150/jca.32927", "PMC6856571", "31762820"]}, {"Citation": "Feng Q., Zhang C., Lum D., Druso J. E., Blank B., Wilson K. F., et al. (2017). A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis. Nat. Commun. 8 (1), 14450\u201314517. 10.1038/ncomms14450", "ArticleIdList": ["10.1038/ncomms14450", "PMC5316898", "28205552"]}, {"Citation": "Feng Z., Xu X., Cen D., Luo C., Wu S. (2017). miR-590-3p promotes colon cancer cell proliferation via Wnt/\u03b2-catenin signaling pathway by inhibiting WIF1 and DKK1. Eur. Rev. Med. Pharmacol. Sci. 21 (21), 4844\u20134852.", "ArticleIdList": ["29164578"]}, {"Citation": "Fluge \u00d8., Gravdal K., Carlsen E., Vonen B., Kjellevold K., Refsum S., et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br. J. Cancer 101 (8), 1282\u20131289. 10.1038/sj.bjc.6605333", "ArticleIdList": ["10.1038/sj.bjc.6605333", "PMC2768450", "19773751"]}, {"Citation": "Fu C., Wang S., Jin L., Zhang M., Li M. (2021). CircTET1 inhibits retinoblastoma progression via targeting miR-492 and miR-494-3p through wnt/\u03b2-catenin signaling pathway. Curr. Eye Res. 46 (7), 978\u2013987. 10.1080/02713683.2020.1843685", "ArticleIdList": ["10.1080/02713683.2020.1843685", "33108919"]}, {"Citation": "Fu K., Zhang K., Zhang X. (2022). LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis. Orphanet J. Rare Dis. 17 (1), 119. 10.1186/s13023-022-02206-y", "ArticleIdList": ["10.1186/s13023-022-02206-y", "PMC8898492", "35248107"]}, {"Citation": "Fuchs B., Zhang K., Schabel A., Bolander M. E., Sarkar G. (2001). Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene 278 (1-2), 245\u2013252. 10.1016/s0378-1119(01)00731-4", "ArticleIdList": ["10.1016/s0378-1119(01)00731-4", "11707342"]}, {"Citation": "Gao J., Dai C., Yu X., Yin X. B., Zhou F. (2021). Long noncoding RNA LEF1\u2010AS1 acts as a microRNA\u201010a\u20105p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. J. Cell. Biochem. 122 (1), 86\u201399. 10.1002/jcb.29833", "ArticleIdList": ["10.1002/jcb.29833", "32786108"]}, {"Citation": "Gao M., Cui Z., Zhao D., Zhang S., Cai Q. (2021). MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes Genomics 43 (9), 1023\u20131033. 10.1007/s13258-021-01043-w", "ArticleIdList": ["10.1007/s13258-021-01043-w", "34129195"]}, {"Citation": "Gao Y., Jing M., Ge R., Zhou Z., Sun Y. (2014). Inhibition of hypoxia inducible factor 1\u03b1 by siRNA\u2010induced apoptosis in human retinoblastoma cells. J. Biochem. Mol. Toxicol. 28 (9), 394\u2013399. 10.1002/jbt.21576", "ArticleIdList": ["10.1002/jbt.21576", "24860939"]}, {"Citation": "Gao Y., Luo X., Zhang J. (2021). LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway. Cancer Gene Ther. 28 (1-2), 42\u201354. 10.1038/s41417-020-0181-z", "ArticleIdList": ["10.1038/s41417-020-0181-z", "32439866"]}, {"Citation": "Gao Y., Zhang H., Zhao S., He D., Gu C. (2021). Nanofluorescence probes to detect miR-192/integrin alpha 1 and their correlations with retinoblastoma. J. Biomed. Nanotechnol. 17 (11), 2176\u20132185. 10.1166/jbn.2021.3185", "ArticleIdList": ["10.1166/jbn.2021.3185", "34906278"]}, {"Citation": "Greco O., Scott S. (2007). Tumor hypoxia and targeted gene therapy. Int. Rev. Cytol. 257, 181\u2013212. 10.1016/S0074-7696(07)57005-1", "ArticleIdList": ["10.1016/S0074-7696(07)57005-1", "17280898"]}, {"Citation": "Grolmusz V. K., Kar\u00e1szi K., Micsik T., T\u00f3th E. A., M\u00e9sz\u00e1ros K., Karvaly G., et al. (2016). Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer. Am. J. Cancer Res. 6 (9), 2041\u20132053.", "ArticleIdList": ["PMC5043113", "27725909"]}, {"Citation": "Grossi F., Dal Bello M. G., Salvi S., Puzone R., Pfeffer U., Fontana V., et al. (2015). Expression of ribonucleotide reductase subunit-2 and thymidylate synthase correlates with poor prognosis in patients with resected stages I\u2013III non-small cell lung cancer. Dis. Markers 2015, 302649. 10.1155/2015/302649", "ArticleIdList": ["10.1155/2015/302649", "PMC4664813", "26663950"]}, {"Citation": "Grzes K. M., Swamy M., Hukelmann J. L., Emslie E., Sinclair L. V., Cantrell D. A. (2017). Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy. Leukemia 31 (12), 2771\u20132779. 10.1038/leu.2017.160", "ArticleIdList": ["10.1038/leu.2017.160", "PMC5729345", "28546582"]}, {"Citation": "Guarnieri D. J., DiLeone R. J. (2008). MicroRNAs: A new class of gene regulators. Ann. Med. 40 (3), 197\u2013208. 10.1080/07853890701771823", "ArticleIdList": ["10.1080/07853890701771823", "18382885"]}, {"Citation": "Gui F., Hong Z., You Z., Wu H., Zhang Y. (2016). MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway. Cell Biol. Int. 40 (12), 1294\u20131302. 10.1002/cbin.10678", "ArticleIdList": ["10.1002/cbin.10678", "27600360"]}, {"Citation": "Guo H., Zhou S., Tan L., Wu X., Wu Z., Ran R. (2017). Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review. Oncotarget 8 (2), 2550\u20132557. 10.18632/oncotarget.13707", "ArticleIdList": ["10.18632/oncotarget.13707", "PMC5356219", "27911280"]}, {"Citation": "Guo L., Bai Y., Ji S., Ma H. (2019). MicroRNA-98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway. Int. J. Oncol. 54 (3), 807\u2013820. 10.3892/ijo.2019.4689", "ArticleIdList": ["10.3892/ijo.2019.4689", "PMC6365030", "30664191"]}, {"Citation": "Guo L., Bai Y., Ni T., Li Y., Cao R., Ji S., et al. (2021). MicroRNA\u201198 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k\u2011Ras/Raf/MEK/ERK signaling pathway. Int. J. Oncol. 59 (1), 807\u2013820. 10.3892/ijo.2019.4689", "ArticleIdList": ["10.3892/ijo.2019.4689", "PMC6365030", "30664191"]}, {"Citation": "Guo M., Zhang X., Wang G., Sun J., Jiang Z., Khadarian K., et al. (2015). miR-603 promotes glioma cell growth via Wnt/\u03b2-catenin pathway by inhibiting WIF1 and CTNNBIP1. Cancer Lett. 360 (1), 76\u201386. 10.1016/j.canlet.2015.02.003", "ArticleIdList": ["10.1016/j.canlet.2015.02.003", "25681036"]}, {"Citation": "Guo Q., Wang H-B., Li Y-H., Li H-F., Li T-T., Zhang W-X., et al. (2016). Correlations of promoter methylation in WIF-1, RASSF1A, and CDH13 genes with the risk and prognosis of esophageal cancer. Med. Sci. Monit. 22, 2816\u20132824. 10.12659/msm.896877", "ArticleIdList": ["10.12659/msm.896877", "PMC4982528", "27506957"]}, {"Citation": "Guo W., Shao F., Sun S., Song P., Guo L., Xue X., et al. (2020). Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma. J. Cancer 11 (7), 1648\u20131656. 10.7150/jca.39319", "ArticleIdList": ["10.7150/jca.39319", "PMC7052850", "32194777"]}, {"Citation": "Hamasaki M., Furuta N., Matsuda A., Nezu A., Yamamoto A., Fujita N., et al. (2013). Autophagosomes form at ER\u2013mitochondria contact sites. Nature 495 (7441), 389\u2013393. 10.1038/nature11910", "ArticleIdList": ["10.1038/nature11910", "23455425"]}, {"Citation": "Han S., Song L., Chen Y., Hou M., Wei X., Fan D. (2020). The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis. Exp. Cell Res. 393 (2), 112087. 10.1016/j.yexcr.2020.112087", "ArticleIdList": ["10.1016/j.yexcr.2020.112087", "32407730"]}, {"Citation": "Hao B., Shi A., Li X., Li J., Liu Z., Yuan H. (2020). miR-4516 inhibits the apoptosis of RB tumor cells by targeting the PTEN/AKT signaling pathway. Exp. Eye Res. 200, 108224. 10.1016/j.exer.2020.108224", "ArticleIdList": ["10.1016/j.exer.2020.108224", "32919989"]}, {"Citation": "He M. Y., An Y., Gao Y. J., Qian X. W., Li G., Qian J. (2014). Screening of RB1 gene mutations in Chinese patients with retinoblastoma and preliminary exploration of genotype-phenotype correlations. Mol. Vis. 20, 545\u2013552.", "ArticleIdList": ["PMC4000713", "24791139"]}, {"Citation": "He S., Lu Y., Liu X., Huang X., Keller E. T., Qian C-N., et al. (2015). Wnt3a: Functions and implications in cancer. Chin. J. Cancer 34 (3), 554\u2013562. 10.1186/s40880-015-0052-4", "ArticleIdList": ["10.1186/s40880-015-0052-4", "PMC4593336", "26369691"]}, {"Citation": "He T. G., Xiao Z. Y., Xing Y. Q., Yang H. J., Qiu H., Chen J. B. (2019). Tumor suppressor miR-184 enhances chemosensitivity by directly inhibiting SLC7A5 in retinoblastoma. Front. Oncol. 9, 1163. 10.3389/fonc.2019.01163", "ArticleIdList": ["10.3389/fonc.2019.01163", "PMC6876683", "31803607"]}, {"Citation": "He X., Feng Y. (2022). MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression. Anticancer. Drugs 33 (5), 478\u2013488. 10.1097/CAD.0000000000001308", "ArticleIdList": ["10.1097/CAD.0000000000001308", "35324527"]}, {"Citation": "Hou T., Ye L., Wu S. (2021). Knockdown of LINC00504 inhibits the proliferation and invasion of breast cancer via the downregulation of miR-140-5p. Onco. Targets. Ther. 14, 3991\u20134003. 10.2147/OTT.S294965", "ArticleIdList": ["10.2147/OTT.S294965", "PMC8259944", "34239305"]}, {"Citation": "Hsieh J-C., Kodjabachian L., Rebbert M. L., Rattner A., Smallwood P. M., Samos C. H., et al. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398 (6726), 431\u2013436. 10.1038/18899", "ArticleIdList": ["10.1038/18899", "10201374"]}, {"Citation": "Hu C. E., Du P. Z., Zhang H. D., Huang G. J. (2017). Long noncoding RNA CRNDE promotes proliferation of gastric cancer cells by targeting miR-145. Cell. Physiol. biochem. 42 (1), 13\u201321. 10.1159/000477107", "ArticleIdList": ["10.1159/000477107", "28490034"]}, {"Citation": "Hu S., Ran Y., Chen W., Zhang Y., Xu Y. (2017). MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1. Oncol. Rep. 38 (3), 1569\u20131578. 10.3892/or.2017.5810", "ArticleIdList": ["10.3892/or.2017.5810", "28713953"]}, {"Citation": "Hu Y., Zhao M., Li L., Ding J., Gui Y. M., Wei T. W. (2021). miR-491-3p is downregulated in retinoblastoma and inhibit tumor cells growth and metastasis by targeting SNN. Biochem. Genet. 59 (2), 453\u2013474. 10.1007/s10528-020-10007-w", "ArticleIdList": ["10.1007/s10528-020-10007-w", "PMC7946698", "33098307"]}, {"Citation": "Huang G-Q., Ke Z-P., Hu H-B., Gu B. (2017). Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes reveals SFTA1P and CASC2 abnormalities in lung squamous cell carcinoma. Cancer Biol. Ther. 18 (2), 115\u2013122. 10.1080/15384047.2017.1281494", "ArticleIdList": ["10.1080/15384047.2017.1281494", "PMC5362987", "28118064"]}, {"Citation": "Huang J., Yang Y., Fang F., Liu K. (2018). MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation. J. Cell. Biochem. 119 (5), 3853\u20133863. 10.1002/jcb.26464", "ArticleIdList": ["10.1002/jcb.26464", "29073720"]}, {"Citation": "Huang S-M., Lin C., Lin H-Y., Chiu C-M., Fang C-W., Liao K-F., et al. (2015). Brain-derived neurotrophic factor regulates cell motility in human colon cancer. Endocr. Relat. Cancer 22 (3), 455\u2013464. 10.1530/ERC-15-0007", "ArticleIdList": ["10.1530/ERC-15-0007", "25876647"]}, {"Citation": "Huang Y., Du Q., Wu W., She F., Chen Y. (2016). Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins. Mol. Med. Rep. 14 (3), 2573\u20132581. 10.3892/mmr.2016.5532", "ArticleIdList": ["10.3892/mmr.2016.5532", "PMC4991677", "27430608"]}, {"Citation": "Huang Y., Xue B., Pan J., Shen N. (2021). Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression. Exp. Mol. Pathol. 120, 104637. 10.1016/j.yexmp.2021.104637", "ArticleIdList": ["10.1016/j.yexmp.2021.104637", "33844975"]}, {"Citation": "Huang Y. X., Nie X. G., Li G. D., Fan D. S., Song L. L., Zhang X. L. (2018). Downregulation of microRNA-182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation. Int. J. Oncol. 53 (6), 2615\u20132626. 10.3892/ijo.2018.4587", "ArticleIdList": ["10.3892/ijo.2018.4587", "30320366"]}, {"Citation": "Ishimoto T., Shiozaki A., Ichikawa D., Fujiwara H., Konishi H., Komatsu S., et al. (2013). E2F5 as an independent prognostic factor in esophageal squamous cell carcinoma. Anticancer Res. 33 (12), 5415\u20135420.", "ArticleIdList": ["24324077"]}, {"Citation": "Isselbacher E. M., Lino Cardenas C. L., Lindsay M. E. (2016). Hereditary influence in thoracic aortic aneurysm and dissection. Circulation 133 (24), 2516\u20132528. 10.1161/CIRCULATIONAHA.116.009762", "ArticleIdList": ["10.1161/CIRCULATIONAHA.116.009762", "PMC5031368", "27297344"]}, {"Citation": "Itakura E., Kishi-Itakura C., Mizushima N. (2012). The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151 (6), 1256\u20131269. 10.1016/j.cell.2012.11.001", "ArticleIdList": ["10.1016/j.cell.2012.11.001", "23217709"]}, {"Citation": "Ji D., Chen Z., Li M., Zhan T., Yao Y., Zhang Z., et al. (2014). MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol. Cancer 13 (1), 86\u201318. 10.1186/1476-4598-13-86", "ArticleIdList": ["10.1186/1476-4598-13-86", "PMC4021214", "24755295"]}, {"Citation": "Jiang Y., Li Z., Zheng S., Chen H., Zhao X., Gao W., et al. (2016). The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1. Tumour Biol. 37 (3), 3957\u20133967. 10.1007/s13277-015-4234-0", "ArticleIdList": ["10.1007/s13277-015-4234-0", "26482614"]}, {"Citation": "Jiang Y., Xiao F., Wang L., Wang T., Chen L. (2021). Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Mol. Cell. Biochem. 476 (1), 69\u201380. 10.1007/s11010-020-03886-5", "ArticleIdList": ["10.1007/s11010-020-03886-5", "32844346"]}, {"Citation": "Jiang Y., Xiao F., Wang L., Wang T., Chen L. (2021). Hsa_circ_0099198 facilitates the progression of retinoblastoma by regulating miR-1287/LRP6 axis. Exp. Eye Res. 206, 108529. 10.1016/j.exer.2021.108529", "ArticleIdList": ["10.1016/j.exer.2021.108529", "33676964"]}, {"Citation": "Jiang Y., Yim S-H., Xu H-D., Jung S-H., Yang S. Y., Hu H-J., et al. (2011). A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma. World J. Gastroenterol. 17 (4), 470\u2013477. 10.3748/wjg.v17.i4.470", "ArticleIdList": ["10.3748/wjg.v17.i4.470", "PMC3027013", "21274376"]}, {"Citation": "Jin Q., He W., Chen L., Yang Y., Shi K., You Z. (2018). MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9. Exp. Ther. Med. 16 (3), 1663\u20131670. 10.3892/etm.2018.6405", "ArticleIdList": ["10.3892/etm.2018.6405", "PMC6122260", "30186385"]}, {"Citation": "Ke N., Chen L., Liu Q., Xiong H., Chen X., Zhou X. (2022). Downregulation of miR-211-5p promotes carboplatin resistance in human retinoblastoma Y79 cells by affecting the GDNF-LIF interaction. Front. Oncol. 12, 848733. 10.3389/fonc.2022.848733", "ArticleIdList": ["10.3389/fonc.2022.848733", "PMC8925320", "35311096"]}, {"Citation": "Kent L. N., Leone G. (2019). The broken cycle: E2F dysfunction in cancer. Nat. Rev. Cancer 19 (6), 326\u2013338. 10.1038/s41568-019-0143-7", "ArticleIdList": ["10.1038/s41568-019-0143-7", "31053804"]}, {"Citation": "Khan M., Walters L. L., Li Q., Thomas D. G., Miller J. M., Zhang Q., et al. (2015). Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. Lab. Invest. 95 (11), 1278\u20131290. 10.1038/labinvest.2015.104", "ArticleIdList": ["10.1038/labinvest.2015.104", "PMC4626270", "26280220"]}, {"Citation": "Kimura T. (2020). Non-coding natural antisense RNA: Mechanisms of action in the regulation of target gene expression and its clinical implications. Yakugaku Zasshi 140 (5), 687\u2013700. 10.1248/yakushi.20-00002", "ArticleIdList": ["10.1248/yakushi.20-00002", "32378673"]}, {"Citation": "Klaus A., Fathi O., Tatjana T-W., Bruno N., Oskar K. (2018). Expression of hypoxia-associated protein HIF-1\u03b1 in follicular thyroid cancer is associated with distant metastasis. Pathol. Oncol. Res. 24 (2), 289\u2013296. 10.1007/s12253-017-0232-4", "ArticleIdList": ["10.1007/s12253-017-0232-4", "28474313"]}, {"Citation": "Kleer C. G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S. A., et al. (2003). EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 100 (20), 11606\u201311611. 10.1073/pnas.1933744100", "ArticleIdList": ["10.1073/pnas.1933744100", "PMC208805", "14500907"]}, {"Citation": "Kong L., Sun Y., Chen M., Dai Y., Liu Z. (2020). Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3. Exp. Ther. Med. 20 (5), 9. 10.3892/etm.2020.9137", "ArticleIdList": ["10.3892/etm.2020.9137", "PMC7471862", "32934674"]}, {"Citation": "Kothandaraman N., Bajic V. B., Brendan P. N., Huak C. Y., Keow P. B., Razvi K., et al. (2010). E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer. BMC cancer 10 (1), 64\u201313. 10.1186/1471-2407-10-64", "ArticleIdList": ["10.1186/1471-2407-10-64", "PMC2841139", "20181230"]}, {"Citation": "Kuzmichev A., Jenuwein T., Tempst P., Reinberg D. (2004). Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14 (2), 183\u2013193. 10.1016/s1097-2765(04)00185-6", "ArticleIdList": ["10.1016/s1097-2765(04)00185-6", "15099518"]}, {"Citation": "Lassmann S., Weis R., Makowiec F., Roth J., Danciu M., Hopt U., et al. (2007). Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal-and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med. 85 (3), 293\u2013304. 10.1007/s00109-006-0126-5", "ArticleIdList": ["10.1007/s00109-006-0126-5", "17143621"]}, {"Citation": "Lee S. M., Park J. Y., Kim D. S. (2013). Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation. Mol. Cells 36 (1), 69\u201373. 10.1007/s10059-013-0060-7", "ArticleIdList": ["10.1007/s10059-013-0060-7", "PMC3887922", "23686431"]}, {"Citation": "Lei Q., Shen F., Wu J., Zhang W., Wang J., Zhang L. (2014). MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2. Oncol. Rep. 32 (1), 261\u2013269. 10.3892/or.2014.3167", "ArticleIdList": ["10.3892/or.2014.3167", "24807198"]}, {"Citation": "Leonel C., Carvalho Ferreira L., Ferraz Borin T., Gobbe Moschetta M., Scavacini Freitas G., Raineri Haddad M., et al. (2017). Inhibition of epithelial-mesenchymal transition in response to treatment with metformin and Y27632 in breast cancer cell lines. Anticancer. Agents Med. Chem. 17 (8), 1113\u20131125. 10.2174/1871520617666170102153954", "ArticleIdList": ["10.2174/1871520617666170102153954", "28042775"]}, {"Citation": "Li C., Wang Z., Chen S., Zhang J., Qu K., Liu C. (2018). MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1. Int. J. Mol. Med. 42 (6), 3309\u20133317. 10.3892/ijmm.2018.3882", "ArticleIdList": ["10.3892/ijmm.2018.3882", "PMC6202085", "30221686"]}, {"Citation": "Li C., Zhao J., Sun W. (2020). microRNA-222-Mediated VHL downregulation facilitates retinoblastoma chemoresistance by increasing HIF1\u03b1 expression. Invest. Ophthalmol. Vis. Sci. 61 (10), 9. 10.1167/iovs.61.10.9", "ArticleIdList": ["10.1167/iovs.61.10.9", "PMC7441340", "32756923"]}, {"Citation": "Li H., Fan D., Wang W., Zhang X., Song L., Huang Y. (2021). MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN. Biochem. Biophys. Res. Commun. 574, 20\u201326. 10.1016/j.bbrc.2021.07.099", "ArticleIdList": ["10.1016/j.bbrc.2021.07.099", "34425282"]}, {"Citation": "Li J., Liu X., Wang W., Li C. (2020). miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma. Arch. Med. Sci. 16 (4), 941\u2013956. 10.5114/aoms.2019.86901", "ArticleIdList": ["10.5114/aoms.2019.86901", "PMC7286343", "32542098"]}, {"Citation": "Li J., Ma M., Yang X., Zhang M., Luo J., Zhou H., et al. (2020). Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab. Mol. Cancer 19 (1), 142\u2013218. 10.1186/s12943-020-01259-6", "ArticleIdList": ["10.1186/s12943-020-01259-6", "PMC7488427", "32917240"]}, {"Citation": "Li J., Yang J., Zhou P., Le Y., Zhou C., Wang S., et al. (2015). Circular RNAs in cancer: Novel insights into origins, properties, functions and implications. Am. J. Cancer Res. 5 (2), 472\u2013480.", "ArticleIdList": ["PMC4396047", "25973291"]}, {"Citation": "Li J., Zhang Y., Wang X., Zhao R. (2017). microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A. Oncol. Lett. 13 (6), 5021\u20135027. 10.3892/ol.2017.6083", "ArticleIdList": ["10.3892/ol.2017.6083", "PMC5452910", "28588740"]}, {"Citation": "Li K., Han F., Wu Y., Wang X. (2021). miR-340 promotes retinoblastoma cell proliferation, migration and invasion through targeting WIF1. Onco. Targets. Ther. 14, 3635\u20133648. 10.2147/OTT.S302800", "ArticleIdList": ["10.2147/OTT.S302800", "PMC8187089", "34113129"]}, {"Citation": "Li L., Yu H., Ren Q. (2020). MiR-218-5p suppresses the progression of retinoblastoma through targeting NACC1 and inhibiting the AKT/mTOR signaling pathway. Cancer Manag. Res. 12, 6959\u20136967. 10.2147/CMAR.S246142", "ArticleIdList": ["10.2147/CMAR.S246142", "PMC7418178", "32821163"]}, {"Citation": "Li M., Chen X. M., Wang D. M., Gan L., Qiao Y. (2016). Effects of miR-26a on the expression of Beclin 1 in retinoblastoma cells. Genet. Mol. Res. 15 (2). 10.4238/gmr.15028193", "ArticleIdList": ["10.4238/gmr.15028193", "27421000"]}, {"Citation": "Li W., Sun M., Zang C., Ma P., He J., Zhang M., et al. (2016). Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis. 7 (5), e2225\u2013e. 10.1038/cddis.2016.126", "ArticleIdList": ["10.1038/cddis.2016.126", "PMC4917662", "27195672"]}, {"Citation": "Li W., Wang J., Zhang D., Zhang X., Xu J., Zhao L. (2019). MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/\u03b2-catenin pathway. Cancer Biomark. 25 (1), 79\u201388. 10.3233/CBM-182315", "ArticleIdList": ["10.3233/CBM-182315", "31033463"]}, {"Citation": "Li X., Yang L., Shuai T., Piao T., Wang R. (2016). MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression. Biomed. Pharmacother. = Biomedecine Pharmacother. 82, 247\u2013255. 10.1016/j.biopha.2016.05.003", "ArticleIdList": ["10.1016/j.biopha.2016.05.003", "27470361"]}, {"Citation": "Li Y., Zheng Y. (2017). Hypoxia promotes invasion of retinoblastoma cells in vitro by upregulating HIF-1\u03b1/MMP9 signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 21 (23), 5361\u20135369. 10.26355/eurrev_201712_13921", "ArticleIdList": ["10.26355/eurrev_201712_13921", "29243776"]}, {"Citation": "Li Z. N., Ge M. X., Cao L. J., Yuan Z. F. (2020). lncRNA RHPN1-AS1 serves as a sponge for miR-3133 modulating the cell proliferation of retinoblastoma through JAK2. Biomed. Res. Int. 2020, 3502981. 10.1155/2020/3502981", "ArticleIdList": ["10.1155/2020/3502981", "PMC7773464", "33426053"]}, {"Citation": "Liang T., Fan M., Meng Z., Sun B., Mi S., Gao X. (2022). Circ_0000527 drives retinoblastoma progression by regulating miR-1236-3p/SMAD2 pathway. Curr. Eye Res. 47 (4), 624\u2013633. 10.1080/02713683.2021.2007535", "ArticleIdList": ["10.1080/02713683.2021.2007535", "34963405"]}, {"Citation": "Liang Y., Chen X., Liang Z. (2017). MicroRNA-320 regulates autophagy in retinoblastoma by targeting hypoxia inducible factor-1\u03b1. Exp. Ther. Med. 14 (3), 2367\u20132372. 10.3892/etm.2017.4779", "ArticleIdList": ["10.3892/etm.2017.4779", "PMC5609094", "28962169"]}, {"Citation": "Liang Y., Wang H., Song R., Yin X. (2022). lncRNA FOXD2-AS1 promotes the retinoblastoma cell viability and migration by sponging miR-31. Biomed. Res. Int. 2022, 7723425. 10.1155/2022/7723425", "ArticleIdList": ["10.1155/2022/7723425", "PMC9246629", "35782084"]}, {"Citation": "Liang Y., Zheng T., Song R., Wang J., Yin D., Wang L., et al. (2013). Hypoxia\u2010mediated sorafenib resistance can be overcome by EF24 through Von Hippel\u2010Lindau tumor suppressor\u2010dependent HIF\u20101\u03b1 inhibition in hepatocellular carcinoma. Hepatology 57 (5), 1847\u20131857. 10.1002/hep.26224", "ArticleIdList": ["10.1002/hep.26224", "23299930"]}, {"Citation": "Lin B., Hong H., Jiang X., Li C., Zhu S., Tang N., et al. (2017). WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival. Gene 622, 42\u201349. 10.1016/j.gene.2017.04.034", "ArticleIdList": ["10.1016/j.gene.2017.04.034", "28438695"]}, {"Citation": "Lin X-J., Fang J-H., Yang X-J., Zhang C., Yuan Y., Zheng L., et al. (2018). Hepatocellular carcinoma cell-secreted exosomal microRNA-210 promotes angiogenesis in vitro and in vivo . Mol. Ther. Nucleic Acids 11, 243\u2013252. 10.1016/j.omtn.2018.02.014", "ArticleIdList": ["10.1016/j.omtn.2018.02.014", "PMC5992447", "29858059"]}, {"Citation": "Liu B., Lu B., Wang X., Jiang H., Kuang W. (2019). MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8. Childs Nerv. Syst. 35 (8), 1303\u20131311. 10.1007/s00381-019-04199-9", "ArticleIdList": ["10.1007/s00381-019-04199-9", "31161266"]}, {"Citation": "Liu F., Zhang Q., Liang Y. (2020). MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway. J. Cell. Biochem. 121 (3), 2294\u20132302. 10.1002/jcb.29453", "ArticleIdList": ["10.1002/jcb.29453", "31674056"]}, {"Citation": "Liu H., Cao B., Zhao Y., Liang H., Liu X. (2018). Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma. Cancer Biomark. 22 (4), 621\u2013629. 10.3233/CBM-170721", "ArticleIdList": ["10.3233/CBM-170721", "29843209"]}, {"Citation": "Liu H., Yuan H. F., Xu D., Chen K. J., Tan N., Zheng Q. J. (2020). Circular RNA circ_0000034 upregulates STX17 level to promote human retinoblastoma development via inhibiting miR-361-3p. Eur. Rev. Med. Pharmacol. Sci. 24 (23), 12080\u201312092. 10.26355/eurrev_202012_23997", "ArticleIdList": ["10.26355/eurrev_202012_23997", "33336726"]}, {"Citation": "Liu K., Huang J., Xie M., Yu Y., Zhu S., Kang R., et al. (2014). MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy 10 (3), 442\u2013452. 10.4161/auto.27418", "ArticleIdList": ["10.4161/auto.27418", "PMC4077883", "24418846"]}, {"Citation": "Liu L., Xiao C., Sun Q. (2022). MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway. Cutan. Ocul. Toxicol. 41 (1), 1\u201310. 10.1080/15569527.2021.1994587", "ArticleIdList": ["10.1080/15569527.2021.1994587", "34711123"]}, {"Citation": "Liu M., Wang S. M., Jiang Z. X., Lauren H., Tao L. M. (2018). Effects of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma Y79 cells by targeting high-mobility group box 1. Int. J. Ophthalmol. 11 (10), 1600\u20131607. 10.18240/ijo.2018.10.05", "ArticleIdList": ["10.18240/ijo.2018.10.05", "PMC6192956", "30364183"]}, {"Citation": "Liu P., Shen J. K., Hornicek F. J., Liu F., Duan Z. (2017). Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma. Sci. Rep. 7 (1), 1580\u20131611. 10.1038/s41598-017-01763-8", "ArticleIdList": ["10.1038/s41598-017-01763-8", "PMC5431504", "28484252"]}, {"Citation": "Liu S., Wen C. (2022). miR-141-3p promotes retinoblastoma progression via inhibiting sushi domain-containing protein 2. Bioengineered 13 (3), 7410\u20137424. 10.1080/21655979.2022.2048770", "ArticleIdList": ["10.1080/21655979.2022.2048770", "PMC8973658", "35259051"]}, {"Citation": "Liu S., Yan G., Zhang J., Yu L. (2018). Knockdown of long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) inhibits proliferation, migration, and invasion and promotes apoptosis by targeting miR-124 in retinoblastoma. Oncol. Res. 26 (4), 581\u2013591. 10.3727/096504017X14953948675403", "ArticleIdList": ["10.3727/096504017X14953948675403", "PMC7844671", "28550678"]}, {"Citation": "Liu S., Zhang X., Hu C., Wang Y., Xu C. (2018). miR-29a inhibits human retinoblastoma progression by targeting STAT3. Oncol. Rep. 39 (2), 739\u2013746. 10.3892/or.2017.6144", "ArticleIdList": ["10.3892/or.2017.6144", "29251322"]}, {"Citation": "Liu X., Li X., Li J. (2021). Long non-coding RNA FEZF1-AS1 promotes growth and reduces apoptosis through regulation of miR-363-3p/PAX6 Axis in retinoblastoma. Biochem. Genet. 59 (3), 637\u2013651. 10.1007/s10528-020-10026-7", "ArticleIdList": ["10.1007/s10528-020-10026-7", "PMC8096736", "33432525"]}, {"Citation": "Liu X. M., Li X. F., Li J. C. (2021). MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1. Kaohsiung J. Med. Sci. 37 (4), 286\u2013293. 10.1002/kjm2.12337", "ArticleIdList": ["10.1002/kjm2.12337", "33340248"]}, {"Citation": "Liu Y., Li H., Liu Y., Zhu Z. (2018). MiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cells. Biomed. Pharmacother. = Biomedecine Pharmacother. 105, 805\u2013812. 10.1016/j.biopha.2018.06.038", "ArticleIdList": ["10.1016/j.biopha.2018.06.038", "29913409"]}, {"Citation": "Liu Y., Liang G., Wang H., Liu Z. (2019). MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6. Pathol. Res. Pract. 215 (12), 152641. 10.1016/j.prp.2019.152641", "ArticleIdList": ["10.1016/j.prp.2019.152641", "31727502"]}, {"Citation": "Liu Z., Huang Y., Zhang F., Tang H., Wang Y. (2020). Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis. Ann. Transl. Med. 8 (21), 1451. 10.21037/atm-20-6009", "ArticleIdList": ["10.21037/atm-20-6009", "PMC7723560", "33313196"]}, {"Citation": "Lu X., Tu H., Tang D., Huang X., Sun F. (2022). miR-130a-3p enhances the chemosensitivity of Y79 retinoblastoma cells to vincristine by targeting PAX6 expression. Curr. Eye Res. 47 (3), 418\u2013425. 10.1080/02713683.2021.1984537", "ArticleIdList": ["10.1080/02713683.2021.1984537", "34547965"]}, {"Citation": "Luo Z., Rong Z., Zhang J., Zhu Z., Yu Z., Li T., et al. (2020). Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Mol. Cancer 19 (1), 86\u201321. 10.1186/s12943-020-01203-8", "ArticleIdList": ["10.1186/s12943-020-01203-8", "PMC7210689", "32386516"]}, {"Citation": "Lv X., Yang H., Zhong H., He L., Wang L. (2022). Osthole exhibits an antitumor effect in retinoblastoma through inhibiting the PI3K/AKT/mTOR pathway via regulating the hsa_circ_0007534/miR-214-3p axis. Pharm. Biol. 60 (1), 417\u2013426. 10.1080/13880209.2022.2032206", "ArticleIdList": ["10.1080/13880209.2022.2032206", "PMC8856102", "35175172"]}, {"Citation": "Lytle J. R., Yario T. A., Steitz J. A. (2007). Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5\u2032 UTR as in the 3\u2032 UTR. Proc. Natl. Acad. Sci. U. S. A. 104 (23), 9667\u20139672. 10.1073/pnas.0703820104", "ArticleIdList": ["10.1073/pnas.0703820104", "PMC1887587", "17535905"]}, {"Citation": "Lyv X., Wu F., Zhang H., Lu J., Wang L., Ma Y. (2020). Long noncoding RNA ZFPM2-AS1 knockdown restrains the development of retinoblastoma by modulating the MicroRNA-515/HOXA1/wnt/\u03b2-catenin Axis. Invest. Ophthalmol. Vis. Sci. 61 (6), 41. 10.1167/iovs.61.6.41", "ArticleIdList": ["10.1167/iovs.61.6.41", "PMC7415309", "32561925"]}, {"Citation": "Ma X., Jin L., Lei X., Tong J., Wang R. (2020). MicroRNA-363-3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA. Oncol. Rep. 43 (5), 1365\u20131374. 10.3892/or.2020.7544", "ArticleIdList": ["10.3892/or.2020.7544", "PMC7107813", "32323827"]}, {"Citation": "Machihara K., Namba T. (2019). BAP31 inhibits cell adaptation to ER stress conditions, negatively regulating autophagy induction by interaction with STX17. Cells 8 (11), 1350. 10.3390/cells8111350", "ArticleIdList": ["10.3390/cells8111350", "PMC6912744", "31671609"]}, {"Citation": "Madhavan J., Mitra M., Mallikarjuna K., Pranav O., Srinivasan R., Nagpal A., et al. (2009). KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association. Mol. Vis. 15, 235\u2013240.", "ArticleIdList": ["PMC2633458", "19190782"]}, {"Citation": "Maheshwari A., Finger P. T. (2018). Cancers of the eye. Cancer Metastasis Rev. 37 (4), 677\u2013690. 10.1007/s10555-018-9762-9", "ArticleIdList": ["10.1007/s10555-018-9762-9", "30203109"]}, {"Citation": "Marks P. A., Richon V. M., Kelly W. K., Chiao J. H., Miller T. (Editors) (2004). \u201cHistone deacetylase inhibitors: Development as cancer therapy,\u201d Reversible protein acetylation: Novartis foundation symposium 259 (Wiley Online Library; ).", "ArticleIdList": ["15171260"]}, {"Citation": "Martin A., Jones A., Bryar P. J., Mets M., Weinstein J., Zhang G., et al. (2013). MicroRNAs-449a and -449b exhibit tumor suppressive effects in retinoblastoma. Biochem. Biophys. Res. Commun. 440 (4), 599\u2013603. 10.1016/j.bbrc.2013.09.117", "ArticleIdList": ["10.1016/j.bbrc.2013.09.117", "24120948"]}, {"Citation": "McAllister A. (2001). Neurotrophins and neuronal differentiation in the central nervous system. Cell. Mol. Life Sci. 58 (8), 1054\u20131060. 10.1007/PL00000920", "ArticleIdList": ["10.1007/PL00000920", "11529498"]}, {"Citation": "Memczak S., Jens M., Elefsinioti A., Torti F., Krueger J., Rybak A., et al. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495 (7441), 333\u2013338. 10.1038/nature11928", "ArticleIdList": ["10.1038/nature11928", "23446348"]}, {"Citation": "Meng X., Zhang Y., Hu Y., Zhong J., Jiang C., Zhang H. (2021). LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2. Cell. Signal. 86, 110088. 10.1016/j.cellsig.2021.110088", "ArticleIdList": ["10.1016/j.cellsig.2021.110088", "34265414"]}, {"Citation": "Miao X., Wang Z., Chen B., Chen Y., Wang X., Jiang L., et al. (2018). miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3. Cell. Mol. Biol. 64 (6), 42\u201347. 10.14715/cmb/2018.64.6.8", "ArticleIdList": ["10.14715/cmb/2018.64.6.8", "29808799"]}, {"Citation": "Mohammad F., Weissmann S., Leblanc B., Pandey D. P., H\u00f8jfeldt J. W., Comet I., et al. (2017). EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat. Med. 23 (4), 483\u2013492. 10.1038/nm.4293", "ArticleIdList": ["10.1038/nm.4293", "28263309"]}, {"Citation": "Montoya V., Fan H., Bryar P. J., Weinstein J. L., Mets M. B., Feng G., et al. (2015). Novel miRNA-31 and miRNA-200a-mediated regulation of retinoblastoma proliferation. PloS one 10 (9), e0138366. 10.1371/journal.pone.0138366", "ArticleIdList": ["10.1371/journal.pone.0138366", "PMC4574557", "26379276"]}, {"Citation": "Ni W., Li Z., Ai K. (2022). lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis. Bioengineered 13 (1), 1637\u20131649. 10.1080/21655979.2021.2021346", "ArticleIdList": ["10.1080/21655979.2021.2021346", "PMC8805943", "34989314"]}, {"Citation": "Nie C., Ma H., Gao Y., Li J., Tang Z., Chen Y., et al. (2021). RNA sequencing and bioinformatic analysis on retinoblastoma revealing that cell cycle deregulation is a key process in retinoblastoma tumorigenesis. Ophthalmologica. 244 (1), 51\u201359. 10.1159/000506993", "ArticleIdList": ["10.1159/000506993", "32146475"]}, {"Citation": "Nordlund P., Reichard P. (2006). Ribonucleotide reductases. Annu. Rev. Biochem. 75, 681\u2013706. 10.1146/annurev.biochem.75.103004.142443", "ArticleIdList": ["10.1146/annurev.biochem.75.103004.142443", "16756507"]}, {"Citation": "Ouyang M., Liu G., Xiong C., Rao J. (2022). microRNA-181a-5p impedes the proliferation, migration, and invasion of retinoblastoma cells by targeting the NRAS proto-oncogene. Clinics 77, 100026. 10.1016/j.clinsp.2022.100026", "ArticleIdList": ["10.1016/j.clinsp.2022.100026", "PMC8961171", "35339759"]}, {"Citation": "Park S. J., Woo S. J., Park K. H. (2014). Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean National Cancer Registry database (1993-2010). Invest. Ophthalmol. Vis. Sci. 55 (5), 2816\u20132821. 10.1167/iovs.14-14078", "ArticleIdList": ["10.1167/iovs.14-14078", "24692122"]}, {"Citation": "Peng X., Yan J., Cheng F. (2020). LncRNA TMPO-AS1 up-regulates the expression of HIF-1\u03b1 and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p. Pathol. Res. Pract. 216 (4), 152853. 10.1016/j.prp.2020.152853", "ArticleIdList": ["10.1016/j.prp.2020.152853", "32139259"]}, {"Citation": "Plousiou M., De Vita A., Miserocchi G., Bandini E., Vannini I., Melloni M., et al. (2022). Growth inhibition of retinoblastoma cell line by exosome-mediated transfer of miR-142-3p. Cancer Manag. Res. 14, 2119\u20132131. 10.2147/CMAR.S351979", "ArticleIdList": ["10.2147/CMAR.S351979", "PMC9250773", "35791342"]}, {"Citation": "Poggi L., Casarosa S., Carl M. (2018). An eye on the Wnt inhibitory factor Wif1. Front. Cell Dev. Biol. 6, 167. 10.3389/fcell.2018.00167", "ArticleIdList": ["10.3389/fcell.2018.00167", "PMC6292148", "30574494"]}, {"Citation": "Pueyo J. I., Magny E. G., Sampson C. J., Amin U., Evans I. R., Bishop S. A., et al. (2016). Hemotin, a regulator of phagocytosis encoded by a small ORF and conserved across metazoans. PLoS Biol. 14 (3), e1002395. 10.1371/journal.pbio.1002395", "ArticleIdList": ["10.1371/journal.pbio.1002395", "PMC4807881", "27015288"]}, {"Citation": "Qi B., Newcomer R. G., Sang Q. X. (2009). ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr. Pharm. Des. 15 (20), 2336\u20132348. 10.2174/138161209788682352", "ArticleIdList": ["10.2174/138161209788682352", "19601835"]}, {"Citation": "Ramachandran I., Ganapathy V., Gillies E., Fonseca I., Sureban S., Houchen C., et al. (2014). Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence. Cell Death Dis. 5 (5), e1246\u2013e. 10.1038/cddis.2014.219", "ArticleIdList": ["10.1038/cddis.2014.219", "PMC4047921", "24853424"]}, {"Citation": "Ramachandran I., Thavathiru E., Ramalingam S., Natarajan G., Mills W., Benbrook D., et al. (2012). Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo . Oncogene 31 (22), 2725\u20132737. 10.1038/onc.2011.455", "ArticleIdList": ["10.1038/onc.2011.455", "22002305"]}, {"Citation": "Rao R., Honavar S. G. (2017). Indian J. Pediatr. 84 (12), 937\u2013944. 10.1007/s12098-017-2395-0", "ArticleIdList": ["10.1007/s12098-017-2395-0", "28620731"]}, {"Citation": "Rashed M. H., Bayraktar E., Helal G. K., Abd-Ellah, Amero P., Chavez-Reyes A., et al. (2017). Exosomes: From garbage bins to promising therapeutic targets. Int. J. Mol. Sci. 18 (3), 538. 10.3390/ijms18030538", "ArticleIdList": ["10.3390/ijms18030538", "PMC5372554", "28257101"]}, {"Citation": "Reese B. E., Davidson C., Billingsley M. L., Yun J. (2005). Protein kinase c\u03f5 regulates tumor necrosis factor-\u03b1-induced stannin gene expression. J. Pharmacol. Exp. Ther. 314 (1), 61\u201369. 10.1124/jpet.105.084236", "ArticleIdList": ["10.1124/jpet.105.084236", "15798003"]}, {"Citation": "Reese B. E., Krissinger D., Yun J. K., Billingsley M. L. (2006). Elucidation of stannin function using microarray analysis: Implications for cell cycle control. Gene Expr. 13 (1), 41\u201352. 10.3727/000000006783991944", "ArticleIdList": ["10.3727/000000006783991944", "PMC6032450", "16572589"]}, {"Citation": "Rong J., Li Z., Xu L., Lang L., Zheng G. (2021). microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1. Cell Cycle 20 (3), 298\u2013307. 10.1080/15384101.2021.1874685", "ArticleIdList": ["10.1080/15384101.2021.1874685", "PMC7889169", "33475455"]}, {"Citation": "Roperch J-P., Incitti R., Forbin S., Bard F., Mansour H., Mesli F., et al. (2013). Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. BMC cancer 13 (1), 566\u2013610. 10.1186/1471-2407-13-566", "ArticleIdList": ["10.1186/1471-2407-13-566", "PMC4219483", "24289328"]}, {"Citation": "Rosilio C., Nebout M., Imbert V., Griessinger E., Neffati Z., Benadiba J., et al. (2015). L-Type amino-acid transporter 1 (LAT1): A therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia. Leukemia 29 (6), 1253\u20131266. 10.1038/leu.2014.338", "ArticleIdList": ["10.1038/leu.2014.338", "25482130"]}, {"Citation": "Sanger H. L., Klotz G., Riesner D., Gross H. J., Kleinschmidt A. K. (1976). Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc. Natl. Acad. Sci. U. S. A. 73 (11), 3852\u20133856. 10.1073/pnas.73.11.3852", "ArticleIdList": ["10.1073/pnas.73.11.3852", "PMC431239", "1069269"]}, {"Citation": "Sha Y., Zmijewski J., Xu Z., Abraham E. (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180 (4), 2531\u20132537. 10.4049/jimmunol.180.4.2531", "ArticleIdList": ["10.4049/jimmunol.180.4.2531", "18250463"]}, {"Citation": "Shao F., Huang M., Meng F., Huang Q. (2018). Circular RNA signature predicts gemcitabine resistance of pancreatic ductal adenocarcinoma. Front. Pharmacol. 9, 584. 10.3389/fphar.2018.00584", "ArticleIdList": ["10.3389/fphar.2018.00584", "PMC5996282", "29922161"]}, {"Citation": "Sharma G. G., Okada Y., Von Hoff D., Goel A. (Editors) (2021). \u201cNon-coding RNA biomarkers in pancreatic ductal adenocarcinoma,\u201d Seminars in cancer biology (Elsevier; ).", "ArticleIdList": ["PMC8035348", "33049362"]}, {"Citation": "Sheets J. N., Patrick M. E., Egland K. A. (2020). SUSD2 expression correlates with decreased metastasis and increased survival in a high-grade serous ovarian cancer xenograft murine model. Oncotarget 11 (24), 2290\u20132301. 10.18632/oncotarget.27626", "ArticleIdList": ["10.18632/oncotarget.27626", "PMC7299533", "32595828"]}, {"Citation": "Shimizu F., Shiiba M., Ogawara K., Kimura R., Minakawa Y., Baba T., et al. (2013). Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer. PloS one 8 (12), e83187. 10.1371/journal.pone.0083187", "ArticleIdList": ["10.1371/journal.pone.0083187", "PMC3873298", "24386158"]}, {"Citation": "Silva A. M., Moura S. R., Teixeira J. H., Barbosa M. A., Santos S. G., Almeida M. I. (2019). Long noncoding RNAs: A missing link in osteoporosis. Bone Res. 7 (1), 10\u201316. 10.1038/s41413-019-0048-9", "ArticleIdList": ["10.1038/s41413-019-0048-9", "PMC6437190", "30937214"]}, {"Citation": "Singh A., Patel P., Patel K. V., Jain K. D., Veerasamy R., Sharma C. P., et al. (2017). Histone deacetylase inhibitors for the treatment of colorectal cancer: Recent progress and future prospects. Curr. Cancer Drug Targets 17 (5), 456\u2013466. 10.2174/1568009617666170109150134", "ArticleIdList": ["10.2174/1568009617666170109150134", "28067178"]}, {"Citation": "Singh M. K., Singh L., Pushker N., Sen S., Sharma A., Chauhan F. A., et al. (2015). Correlation of high mobility group box-1 protein (HMGB1) with clinicopathological parameters in primary retinoblastoma. Pathol. Oncol. Res. 21 (4), 1237\u20131242. 10.1007/s12253-015-9951-6", "ArticleIdList": ["10.1007/s12253-015-9951-6", "26118980"]}, {"Citation": "Song D., Diao J., Yang Y., Chen Y. (2017). MicroRNA-382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF-mediated PI3K/AKT signalling pathway. Mol. Med. Rep. 16 (5), 6428\u20136436. 10.3892/mmr.2017.7396", "ArticleIdList": ["10.3892/mmr.2017.7396", "28901408"]}, {"Citation": "Song J., Zhang Z. (2021). Long non-coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR-335-5p/E2F3 axis. Mol. Med. Rep. 24 (2), 543. 10.3892/mmr.2021.12182", "ArticleIdList": ["10.3892/mmr.2021.12182", "34080033"]}, {"Citation": "Song L., Huang Y., Zhang X., Han S., Hou M., Li H. (2020). Downregulation of microRNA-224-3p hampers retinoblastoma progression via activation of the hippo-YAP signaling pathway by increasing LATS2. Invest. Ophthalmol. Vis. Sci. 61 (3), 32. 10.1167/iovs.61.3.32", "ArticleIdList": ["10.1167/iovs.61.3.32", "PMC7401717", "32186675"]}, {"Citation": "Sun Q. X., Wang R. R., Liu N., Liu C. (2020). Dysregulation of miR-204-3p driven by the viability and motility of retinoblastoma via wnt/\u03b2-catenin pathway in vitro and in vivo . Pathol. Oncol. Res. 26 (3), 1549\u20131558. 10.1007/s12253-019-00722-0", "ArticleIdList": ["10.1007/s12253-019-00722-0", "31482398"]}, {"Citation": "Sun S., Wang R., Yi S., Li S., Wang L., Wang J. (2021). Roles of the microRNA-338-3p/NOVA1 axis in retinoblastoma. Mol. Med. Rep. 23 (5), 394. 10.3892/mmr.2021.12033", "ArticleIdList": ["10.3892/mmr.2021.12033", "PMC8008220", "33760207"]}, {"Citation": "Sun Z., Zhang A., Hou M., Jiang T. (2020). Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered 11 (1), 949\u2013957. 10.1080/21655979.2020.1814670", "ArticleIdList": ["10.1080/21655979.2020.1814670", "PMC8291869", "32892696"]}, {"Citation": "Sun Z., Zhang A., Jiang T., Du Z., Che C., Wang F. (2015). MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19. Int. J. Clin. Exp. Pathol. 8 (11), 14521\u201314527.", "ArticleIdList": ["PMC4713558", "26823772"]}, {"Citation": "Tang J., Gifford C. C., Samarakoon R., Higgins P. J. (2018). Deregulation of negative controls on TGF-\u03b21 signaling in tumor progression. Cancers 10 (6), 159. 10.3390/cancers10060159", "ArticleIdList": ["10.3390/cancers10060159", "PMC6025439", "29799477"]}, {"Citation": "Tang J-Y., Lee J-C., Chang Y-T., Hou M-F., Huang H-W., Liaw C-C., et al. (2013). Long noncoding RNAs-related diseases, cancers, and drugs. Sci. World J. 2013, 943539. 10.1155/2013/943539", "ArticleIdList": ["10.1155/2013/943539", "PMC3690748", "23843741"]}, {"Citation": "Tetreault M-P., Yang Y., Katz J. P. (2013). Kr\u00fcppel-like factors in cancer. Nat. Rev. Cancer 13 (10), 701\u2013713. 10.1038/nrc3582", "ArticleIdList": ["10.1038/nrc3582", "24060862"]}, {"Citation": "Th\u00e9baud B., Stewart D. J. (2012). Exosomes: Cell garbage can, therapeutic carrier, or trojan horse? Am Heart Assoc, 2553\u20132555.", "ArticleIdList": ["23114790"]}, {"Citation": "To K. H., Pajovic S., Gallie B. L., Th\u00e9riault B. L. (2012). Regulation of p14ARF expression by miR-24: A potential mechanism compromising the p53 response during retinoblastoma development. BMC cancer 12, 69. 10.1186/1471-2407-12-69", "ArticleIdList": ["10.1186/1471-2407-12-69", "PMC3305684", "22336108"]}, {"Citation": "Tsai M-C., Spitale R. C., Chang H. Y. (2011). Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res. 71 (1), 3\u20137. 10.1158/0008-5472.CAN-10-2483", "ArticleIdList": ["10.1158/0008-5472.CAN-10-2483", "PMC3057914", "21199792"]}, {"Citation": "Tsai Y-F., Tseng L-M., Hsu C-Y., Yang M-H., Chiu J-H., Shyr Y-M. (2017). Brain-derived neurotrophic factor (BDNF)-TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. PLoS One 12 (6), e0178173. 10.1371/journal.pone.0178173", "ArticleIdList": ["10.1371/journal.pone.0178173", "PMC5467823", "28604807"]}, {"Citation": "Uematsu M., Nishimura T., Sakamaki Y., Yamamoto H., Mizushima N. (2017). Accumulation of undegraded autophagosomes by expression of dominant-negative STX17 (syntaxin 17) mutants. Autophagy 13 (8), 1452\u20131464. 10.1080/15548627.2017.1327940", "ArticleIdList": ["10.1080/15548627.2017.1327940", "PMC5584865", "28598244"]}, {"Citation": "Umemura S., Shirane M., Takekoshi S., Kusakabe T., Itoh J., Egashira N., et al. (2009). Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome. Br. J. Cancer 100 (5), 764\u2013771. 10.1038/sj.bjc.6604900", "ArticleIdList": ["10.1038/sj.bjc.6604900", "PMC2653774", "19259095"]}, {"Citation": "Varambally S., Dhanasekaran S. M., Zhou M., Barrette T. R., Kumar-Sinha C., Sanda M. G., et al. (2002). The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419 (6907), 624\u2013629. 10.1038/nature01075", "ArticleIdList": ["10.1038/nature01075", "12374981"]}, {"Citation": "Vos P. D., Leedman P. J., Filipovska A., Rackham O. (2019). Modulation of miRNA function by natural and synthetic RNA-binding proteins in cancer. Cell. Mol. Life Sci. 76 (19), 3745\u20133752. 10.1007/s00018-019-03163-9", "ArticleIdList": ["10.1007/s00018-019-03163-9", "31165201"]}, {"Citation": "Wan W., Wan W., Long Y., Li Q., Jin X., Wan G., et al. (2019). MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway. Biomed. Pharmacother. 118, 109111. 10.1016/j.biopha.2019.109111", "ArticleIdList": ["10.1016/j.biopha.2019.109111", "31336343"]}, {"Citation": "Wan Z., Zhi N., Wong S., Keyvanfar K., Liu D., Raghavachari N., et al. (2010). Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J. Clin. Invest. 120 (10), 3530\u20133544. 10.1172/JCI41805", "ArticleIdList": ["10.1172/JCI41805", "PMC2947219", "20890043"]}, {"Citation": "Wang B., Heath-Engel H., Zhang D., Nguyen N., Thomas D. Y., Hanrahan J. W., et al. (2008). BAP31 interacts with Sec61 translocons and promotes retrotranslocation of CFTRDeltaF508 via the derlin-1 complex. Cell 133 (6), 1080\u20131092. 10.1016/j.cell.2008.04.042", "ArticleIdList": ["10.1016/j.cell.2008.04.042", "18555783"]}, {"Citation": "Wang F., Zhu Y., Huang Y., McAvoy S., Johnson W. B., Cheung T. H., et al. (2005). Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene 24 (24), 3875\u20133885. 10.1038/sj.onc.1208546", "ArticleIdList": ["10.1038/sj.onc.1208546", "15735666"]}, {"Citation": "Wang G., Wang J-J., Fu X-L., Guang R., To S-S. T. (2017). Advances in the targeting of HIF-1\u03b1 and future therapeutic strategies for glioblastoma multiforme (Review). Oncol. Rep. 37 (2), 657\u2013670. 10.3892/or.2016.5309", "ArticleIdList": ["10.3892/or.2016.5309", "27959421"]}, {"Citation": "Wang H., Li M., Cui H., Song X., Sha Q. (2020). CircDHDDS/miR-361-3p/WNT3A Axis promotes the development of retinoblastoma by regulating proliferation, cell cycle, migration, and invasion of retinoblastoma cells. Neurochem. Res. 45 (11), 2691\u20132702. 10.1007/s11064-020-03112-0", "ArticleIdList": ["10.1007/s11064-020-03112-0", "32865704"]}, {"Citation": "Wang H., Zhang Z., Zhang Y., Li L. (2022). Knockdown of the long noncoding RNA TUG1 suppresses retinoblastoma progression by disrupting the epithelial-mesenchymal transition. Cell Transpl. 31, 9636897221078026. 10.1177/09636897221078026", "ArticleIdList": ["10.1177/09636897221078026", "PMC8862129", "35176897"]}, {"Citation": "Wang H., Zhang Z., Zhang Y., Liu S., Li L. (2021). Long non-coding RNA TP53TG1 upregulates SHCBP1 to promote retinoblastoma progression by sponging miR-33b. Cell Transpl. 30, 9636897211025223. 10.1177/09636897211025223", "ArticleIdList": ["10.1177/09636897211025223", "PMC8278459", "34247545"]}, {"Citation": "Wang H-G., Cao B., Zhang L-X., Song N., Li H., Zhao W-Z., et al. (2017). KLF2 inhibits cell growth via regulating HIF-1\u03b1/Notch-1 signal pathway in human colorectal cancer HCT116 cells. Oncol. Rep. 38 (1), 584\u2013590. 10.3892/or.2017.5708", "ArticleIdList": ["10.3892/or.2017.5708", "28628187"]}, {"Citation": "Wang J., Liu X. H., Yang Z. J., Xie B., Zhong Y. S. (2014). The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells. BMC Cancer 14, 89. 10.1186/1471-2407-14-89", "ArticleIdList": ["10.1186/1471-2407-14-89", "PMC3931292", "24528629"]}, {"Citation": "Wang J. X., Yang Y., Li K. (2018). Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9. J. Cell. Physiol. 233 (10), 6986\u20136995. 10.1002/jcp.26621", "ArticleIdList": ["10.1002/jcp.26621", "29744877"]}, {"Citation": "Wang L., Lyu X., Ma Y., Wu F., Wang L. (2019). MicroRNA-504 targets AEG-1 and inhibits cell proliferation and invasion in retinoblastoma. Mol. Med. Rep. 19 (4), 2935\u20132942. 10.3892/mmr.2019.9923", "ArticleIdList": ["10.3892/mmr.2019.9923", "30720088"]}, {"Citation": "Wang L., Wang L., Li L., Zhang H., Lyu X. (2019). MicroRNA-330 is downregulated in retinoblastoma and suppresses cell viability and invasion by directly targeting ROCK1. Mol. Med. Rep. 20 (4), 3440\u20133447. 10.3892/mmr.2019.10545", "ArticleIdList": ["10.3892/mmr.2019.10545", "31432120"]}, {"Citation": "Wang L., Wang L., Zhang X. (2019). Knockdown of lncRNA HOXA-AS2 inhibits viability, migration and invasion of osteosarcoma cells by miR-124-3p/E2F3. Onco. Targets. Ther. 12, 10851\u201310861. 10.2147/OTT.S220072", "ArticleIdList": ["10.2147/OTT.S220072", "PMC6914662", "31853184"]}, {"Citation": "Wang L., Yi S., Wang R., Wang J. (2021). Long non-coding RNA KCNQ1OT1 promotes proliferation, migration and invasion via targeting miR-134 in retinoblastoma. J. Gene Med. 23 (6), e3336. 10.1002/jgm.3336", "ArticleIdList": ["10.1002/jgm.3336", "33818859"]}, {"Citation": "Wang L., Zhang Y., Xin X. (2020). Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3. Pathol. Res. Pract. 216 (6), 152977. 10.1016/j.prp.2020.152977", "ArticleIdList": ["10.1016/j.prp.2020.152977", "32336590"]}, {"Citation": "Wang L. L., Feng Y. Q., Cheng Y. H. (2017). Effect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression. Int. J. Ophthalmol. 10 (1), 30\u201334. 10.18240/ijo.2017.01.05", "ArticleIdList": ["10.18240/ijo.2017.01.05", "PMC5225345", "28149773"]}, {"Citation": "Wang L. L., Hu H. F., Feng Y. Q. (2016). Suppressive effect of microRNA-143 in retinoblastoma. Int. J. Ophthalmol. 9 (11), 1584\u20131590. 10.18240/ijo.2016.11.08", "ArticleIdList": ["10.18240/ijo.2016.11.08", "PMC5145085", "27990360"]}, {"Citation": "Wang M., Yu F., Wu W., Zhang Y., Chang W., Ponnusamy M., et al. (2017). Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity. Int. J. Biol. Sci. 13 (12), 1497\u20131506. 10.7150/ijbs.22531", "ArticleIdList": ["10.7150/ijbs.22531", "PMC5723916", "29230098"]}, {"Citation": "Wang M., Zhao X., Zhu D., Liu T., Liang X., Liu F., et al. (2017). HIF-1\u03b1 promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J. Exp. Clin. Cancer Res. 36 (1), 60\u201314. 10.1186/s13046-017-0533-1", "ArticleIdList": ["10.1186/s13046-017-0533-1", "PMC5408450", "28449718"]}, {"Citation": "Wang P-S., Wang Z., Yang C. (Editors) (2021). \u201cDysregulations of long non-coding RNAs\u2212 the emerging \u201clnc\u201d in environmental carcinogenesis,\u201d Seminars in cancer biology (Elsevier; ).", "ArticleIdList": ["PMC8487435", "33823237"]}, {"Citation": "Wang Q., Zhu Y., Zuo G., Chen X., Cheng J., Zhang S. (2020). LINC00858 promotes retinoblastoma cell proliferation, migration and invasion by inhibiting miR-3182. Exp. Ther. Med. 19 (2), 999\u20131005. 10.3892/etm.2019.8294", "ArticleIdList": ["10.3892/etm.2019.8294", "PMC6966175", "32010262"]}, {"Citation": "Wang R., Geng N., Zhou Y., Zhang D., Li L., Li J., et al. (2015). Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma. Biomed. Mat. Eng. 26 (1), S2145\u2013S2153. 10.3233/BME-151520", "ArticleIdList": ["10.3233/BME-151520", "26405993"]}, {"Citation": "Wang S., Liu J., Yang Y., Hao F., Zhang L. (2018). PlncRNA\u20101 is overexpressed in retinoblastoma and regulates retinoblastoma cell proliferation and motility through modulating CBR3. IUBMB life 70 (10), 969\u2013975. 10.1002/iub.1886", "ArticleIdList": ["10.1002/iub.1886", "30096220"]}, {"Citation": "Wang X., Li X., Lin F., Sun H., Lin Y., Wang Z., et al. (2021). The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J. Exp. Clin. Cancer Res. 40 (1), 151\u2013217. 10.1186/s13046-021-01957-z", "ArticleIdList": ["10.1186/s13046-021-01957-z", "PMC8088648", "33933142"]}, {"Citation": "Wang X., Su Y., Yin C. (2021). Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis. Bioengineered 12 (2), 11622\u201311633. 10.1080/21655979.2021.1994718", "ArticleIdList": ["10.1080/21655979.2021.1994718", "PMC8809915", "34720057"]}, {"Citation": "Wang Y., Lian Y., Ge C. (2019). MiR-145 changes sensitivity of non-small cell lung cancer to gefitinib through targeting ADAM19. Eur. Rev. Med. Pharmacol. Sci. 23 (13), 5831\u20135839. 10.26355/eurrev_201907_18323", "ArticleIdList": ["10.26355/eurrev_201907_18323", "31298334"]}, {"Citation": "Wang Y., Mo Y., Gong Z., Yang X., Yang M., Zhang S., et al. (2017). Circular RNAs in human cancer. Mol. Cancer 16 (1), 25\u201328. 10.1186/s12943-017-0598-7", "ArticleIdList": ["10.1186/s12943-017-0598-7", "PMC5282898", "28143578"]}, {"Citation": "Wang Y., Sun D., Sheng Y., Guo H., Meng F., Song T. (2020). XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma. World J. Surg. Oncol. 18 (1), 49. 10.1186/s12957-020-01825-8", "ArticleIdList": ["10.1186/s12957-020-01825-8", "PMC7055023", "32127028"]}, {"Citation": "Wang Y., Wang J., Hao H., Luo X. (2020). lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1\u03b1 via sponging miR-153-3p. J. Investig. Med. 68 (8), 1349\u20131356. 10.1136/jim-2020-001431", "ArticleIdList": ["10.1136/jim-2020-001431", "33051357"]}, {"Citation": "Wang Y., Xin D., Zhou L. (2020). LncRNA LINC00152 increases the aggressiveness of human retinoblastoma and enhances carboplatin and adriamycin resistance by regulating MiR-613/yes-associated protein 1 (YAP1) Axis. Med. Sci. Monit. 26, e920886. 10.12659/MSM.920886", "ArticleIdList": ["10.12659/MSM.920886", "PMC7315805", "32541644"]}, {"Citation": "Wang Z., Yao Y. J., Zheng F., Guan Z., Zhang L., Dong N., et al. (2017). Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma. Eur. Rev. Med. Pharmacol. Sci. 21 (24), 5624\u20135629. 10.26355/eurrev_201712_14005", "ArticleIdList": ["10.26355/eurrev_201712_14005", "29271995"]}, {"Citation": "Watson A. P., Evans R. L., Egland K. A. (2013). Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis. Mol. Cancer Res. 11 (1), 74\u201385. 10.1158/1541-7786.MCR-12-0501-T", "ArticleIdList": ["10.1158/1541-7786.MCR-12-0501-T", "PMC4426260", "23131994"]}, {"Citation": "Wei D., Yang L., Lv B., Chen L. (2017). Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1. Mol. Vis. 23, 385\u2013394.", "ArticleIdList": ["PMC5501691", "28706438"]}, {"Citation": "Wildeboer D., Naus S., Amy Sang Q. X., Bartsch J. W., Pagenstecher A. (2006). Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J. Neuropathol. Exp. Neurol. 65 (5), 516\u2013527. 10.1097/01.jnen.0000229240.51490.d3", "ArticleIdList": ["10.1097/01.jnen.0000229240.51490.d3", "16772875"]}, {"Citation": "Wu A., Zhou X., Mi L., Shen J. (2020). LINC00202 promotes retinoblastoma progression by regulating cell proliferation, apoptosis, and aerobic glycolysis through miR-204-5p/HMGCR axis. Open Life Sci. 15 (1), 437\u2013448. 10.1515/biol-2020-0047", "ArticleIdList": ["10.1515/biol-2020-0047", "PMC7874641", "33817232"]}, {"Citation": "Wu J., Fang J., Yang Z., Chen F., Liu J., Wang Y. (2012). Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation. J. Clin. Neurosci. 19 (10), 1428\u20131432. 10.1016/j.jocn.2011.12.023", "ArticleIdList": ["10.1016/j.jocn.2011.12.023", "22901505"]}, {"Citation": "Wu L., Chen Z., Xing Y. (2018). MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6. Cell Biol. Int. 10.1002/cbin.11041", "ArticleIdList": ["10.1002/cbin.11041", "30080301"]}, {"Citation": "Wu L., Chen Z., Zhang J., Xing Y. (2012). Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells. J. Huazhong Univ. Sci. Technol. Med. Sci. = Hua 32 (4), 601\u2013606. 10.1007/s11596-012-1004-8", "ArticleIdList": ["10.1007/s11596-012-1004-8", "22886978"]}, {"Citation": "Wu S., Ai N., Liu Q., Zhang J. (2018). MicroRNA-448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway. Oncol. Rep. 39 (5), 2402\u20132412. 10.3892/or.2018.6302", "ArticleIdList": ["10.3892/or.2018.6302", "29517104"]}, {"Citation": "Wu S., Han M., Zhang C. (2019). Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2. J. Cell. Physiol. 234 (10), 19059\u201319072. 10.1002/jcp.28545", "ArticleIdList": ["10.1002/jcp.28545", "30993715"]}, {"Citation": "Wu X., Zeng Y., Wu S., Zhong J., Wang Y., Xu J. (2015). MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9. FEBS Lett. 589 (5), 645\u2013650. 10.1016/j.febslet.2015.01.030", "ArticleIdList": ["10.1016/j.febslet.2015.01.030", "25647033"]}, {"Citation": "Wu X. Z., Cui H. P., Lv H. J., Feng L. (2019). Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p. Biomed. Pharmacother. 112, 108627. 10.1016/j.biopha.2019.108627", "ArticleIdList": ["10.1016/j.biopha.2019.108627", "30797143"]}, {"Citation": "Wu Z., Chen L., Zhang C., Liu Y. (2021). miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression. J. Mol. Histol. 52 (2), 269\u2013277. 10.1007/s10735-020-09946-w", "ArticleIdList": ["10.1007/s10735-020-09946-w", "33474692"]}, {"Citation": "Xia G., Wang H., Song Z., Meng Q., Huang X., Huang X. (2017). Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). J. Exp. Clin. Cancer Res. 36 (1), 107\u2013114. 10.1186/s13046-017-0579-0", "ArticleIdList": ["10.1186/s13046-017-0579-0", "PMC5553806", "28797284"]}, {"Citation": "Xia W., Wang L., Yu D., Mu X., Zhou X. (2019). Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR-520a-3p/EGFR axis. Mol. Med. Rep. 20 (2), 1333\u20131342. 10.3892/mmr.2019.10363", "ArticleIdList": ["10.3892/mmr.2019.10363", "PMC6625385", "31173241"]}, {"Citation": "Xia Z., Yang X., Wu S., Feng Z., Qu L., Chen X., et al. (2019). LncRNA TP73-AS1 down-regulates miR-139-3p to promote retinoblastoma cell proliferation. Biosci. Rep. 39 (5), BSR20190475. 10.1042/BSR20190475", "ArticleIdList": ["10.1042/BSR20190475", "PMC6509052", "31015368"]}, {"Citation": "Xiang J., Wu Y., Li D-S., Wang Z-Y., Shen Q., Sun T-Q., et al. (2015). miR-584 suppresses invasion and cell migration of thyroid carcinoma by regulating the target oncogene ROCK1. Oncol. Res. Treat. 38 (9), 436\u2013440. 10.1159/000438967", "ArticleIdList": ["10.1159/000438967", "26405762"]}, {"Citation": "Xie H., Kang Y., Wang S., Zheng P., Chen Z., Roy S., et al. (2020). E2f5 is a versatile transcriptional activator required for spermatogenesis and multiciliated cell differentiation in zebrafish. PLoS Genet. 16 (3), e1008655. 10.1371/journal.pgen.1008655", "ArticleIdList": ["10.1371/journal.pgen.1008655", "PMC7112233", "32196499"]}, {"Citation": "Xu C., Tian L. H. (2020). LncRNA XIST promotes proliferation and epithelial-mesenchymal transition of retinoblastoma cells through sponge action of miR-142-5p. Eur. Rev. Med. Pharmacol. Sci. 24 (18), 9256\u20139264. 10.26355/eurrev_202009_23007", "ArticleIdList": ["10.26355/eurrev_202009_23007", "33015766"]}, {"Citation": "Xu F., Liu G., Wang L., Wang X., Jin X., Bo W. (2020). miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway. Oncol. Lett. 20 (2), 1952\u20131960. 10.3892/ol.2020.11749", "ArticleIdList": ["10.3892/ol.2020.11749", "PMC7377044", "32724440"]}, {"Citation": "Xu H. K., Wang X. D., Wang D. G., Wei D. D., Liang L., Liu C. H. (2021). miR-340 exerts suppressive effect on retinoblastoma progression by targeting KIF14. Curr. Eye Res. 46 (2), 232\u2013238. 10.1080/02713683.2020.1795202", "ArticleIdList": ["10.1080/02713683.2020.1795202", "32757684"]}, {"Citation": "Xu L., Li W., Shi Q., Wang M., Li H., Yang X., et al. (2020). MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway. Oncol. Rep. 43 (2), 635\u2013645. 10.3892/or.2020.7456", "ArticleIdList": ["10.3892/or.2020.7456", "PMC6967128", "31922233"]}, {"Citation": "Xu L., Long H., Zhou B., Jiang H., Cai M. (2021). CircMKLN1 suppresses the progression of human retinoblastoma by modulation of miR-425-5p/PDCD4 Axis. Curr. Eye Res. 46 (11), 1751\u20131761. 10.1080/02713683.2021.1927110", "ArticleIdList": ["10.1080/02713683.2021.1927110", "33988065"]}, {"Citation": "Xu L., Zhu S., Tang A., Liu W. (2021). LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/\u03b2-catenin signaling pathway. Inflamm. Res. 70 (2), 217\u2013227. 10.1007/s00011-020-01432-z", "ArticleIdList": ["10.1007/s00011-020-01432-z", "33454803"]}, {"Citation": "Xu X., Jia R., Zhou Y., Song X., Wang J., Qian G., et al. (2011). Microarray-based analysis: Identification of hypoxia-regulated microRNAs in retinoblastoma cells. Int. J. Oncol. 38 (5), 1385\u20131393. 10.3892/ijo.2011.961", "ArticleIdList": ["10.3892/ijo.2011.961", "21373755"]}, {"Citation": "Xu X., Zhao Y., Duan G., Du B. (2021). Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR-665 and regulating LASP1. Exp. Ther. Med. 22 (5), 1342. 10.3892/etm.2021.10777", "ArticleIdList": ["10.3892/etm.2021.10777", "PMC8495550", "34630696"]}, {"Citation": "Xu Y., Fu Z., Gao X., Wang R., Li Q. (2021). Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor. Bioengineered 12 (1), 1587\u20131598. 10.1080/21655979.2021.1918991", "ArticleIdList": ["10.1080/21655979.2021.1918991", "PMC8806257", "33942699"]}, {"Citation": "Yan G., Su Y., Ma Z., Yu L., Chen N. (2019). Long noncoding RNA LINC00202 promotes tumor progression by sponging miR-3619-5p in retinoblastoma. Cell Struct. Funct. 44 (1), 51\u201360. 10.1247/csf.18033", "ArticleIdList": ["10.1247/csf.18033", "30905893"]}, {"Citation": "Yan J., Deng Y. X., Cai Y. L., Cong W. D. (2022). LncRNA MIR17HG promotes the proliferation, migration, and invasion of retinoblastoma cells by up-regulating HIF-1\u03b1 expression via sponging miR-155-5p. Kaohsiung J. Med. Sci. 38 (6), 554\u2013564. 10.1002/kjm2.12523", "ArticleIdList": ["10.1002/kjm2.12523", "35253975"]}, {"Citation": "Yan P., Liu J., Zhou R., Lin C., Wu K., Yang S., et al. (2020). LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion. Oncogene 39 (35), 5743\u20135755. 10.1038/s41388-020-01397-7", "ArticleIdList": ["10.1038/s41388-020-01397-7", "32704133"]}, {"Citation": "Yan T-f., Wu M-j., Xiao B., Hu Q., Fan Y-H., Zhu X-G. (2018). Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo. Pathol. Res. Pract. 214 (11), 1818\u20131824. 10.1016/j.prp.2018.09.001", "ArticleIdList": ["10.1016/j.prp.2018.09.001", "30228024"]}, {"Citation": "Yanai H., Ban T., Wang Z., Choi M. K., Kawamura T., Negishi H., et al. (2009). HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462 (7269), 99\u2013103. 10.1038/nature08512", "ArticleIdList": ["10.1038/nature08512", "19890330"]}, {"Citation": "Yang F., Zhou X., Du S., Zhao Y., Ren W., Deng Q., et al. (2014). LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer. PloS one 9 (6), e100557. 10.1371/journal.pone.0100557", "ArticleIdList": ["10.1371/journal.pone.0100557", "PMC4067378", "24955835"]}, {"Citation": "Yang G., Fu Y., Lu X., Wang M., Dong H., Li Q. (2019). miR-34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE-A/p53 signaling. Int. J. Oncol. 54 (1), 177\u2013187. 10.3892/ijo.2018.4613", "ArticleIdList": ["10.3892/ijo.2018.4613", "30387834"]}, {"Citation": "Yang G., Fu Y., Zhang L., Lu X., Li Q. (2017). miR106b regulates retinoblastoma Y79 cells through Runx3. Oncol. Rep. 38 (5), 3039\u20133043. 10.3892/or.2017.5931", "ArticleIdList": ["10.3892/or.2017.5931", "28901461"]}, {"Citation": "Yang H., Huang Y., He J., Chai G., Di Y., Wang A., et al. (2020). MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1. Biosci. Rep. 40 (6), BSR20200392. 10.1042/BSR20200392", "ArticleIdList": ["10.1042/BSR20200392", "PMC7273916", "32401301"]}, {"Citation": "Yang L., Wei N., Wang L., Wang X., Liu Q. H. (2018). miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1. Childs Nerv. Syst. 34 (3), 417\u2013422. 10.1007/s00381-017-3622-8", "ArticleIdList": ["10.1007/s00381-017-3622-8", "29247256"]}, {"Citation": "Yang L., Zhang L., Lu L., Wang Y. (2020). lncRNA UCA1 increases proliferation and multidrug resistance of retinoblastoma cells through downregulating miR-513a-5p. DNA Cell Biol. 39 (1), 69\u201377. 10.1089/dna.2019.5063", "ArticleIdList": ["10.1089/dna.2019.5063", "31702387"]}, {"Citation": "Yang L., Zhang L., Lu L., Wang Y. (2019). Long noncoding RNA SNHG16 sponges miR-182-5p and miR-128-3p to promote retinoblastoma cell migration and invasion by targeting LASP1. Onco. Targets. Ther. 12, 8653\u20138662. 10.2147/OTT.S212352", "ArticleIdList": ["10.2147/OTT.S212352", "PMC6855619", "31806989"]}, {"Citation": "Yang L., Zhang L., Lu L., Wang Y. (2020). miR-214-3p regulates multi-drug resistance and apoptosis in retinoblastoma cells by targeting ABCB1 and XIAP. Onco. Targets. Ther. 13, 803\u2013811. 10.2147/OTT.S235862", "ArticleIdList": ["10.2147/OTT.S235862", "PMC6995305", "32095078"]}, {"Citation": "Yang L. L., Li Q., Zhang X., Cao T. (2020). Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells. Eur. Rev. Med. Pharmacol. Sci. 24 (20), 10433\u201310444. 10.26355/eurrev_202010_23395", "ArticleIdList": ["10.26355/eurrev_202010_23395", "33155266"]}, {"Citation": "Yao L., Yang L., Song H., Liu T. G., Yan H. (2020). Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p. Eur. Rev. Med. Pharmacol. Sci. 24 (7), 3526\u20133537. 10.26355/eurrev_202004_20812", "ArticleIdList": ["10.26355/eurrev_202004_20812", "32329826"]}, {"Citation": "Yao S., Yan W. (2018). Overexpression of Mst1 reduces gastric cancer cell viability by repressing the AMPK-Sirt3 pathway and activating mitochondrial fission. Onco. Targets. Ther. 11, 8465\u20138479. 10.2147/OTT.S180851", "ArticleIdList": ["10.2147/OTT.S180851", "PMC6278716", "30555239"]}, {"Citation": "Yao X., Shen H., Peng Q., Yu J. (2021). TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma. Cell cycleGeorget. Tex) 20 (5-6), 603\u2013615. 10.1080/15384101.2021.1892321", "ArticleIdList": ["10.1080/15384101.2021.1892321", "PMC8018471", "33678118"]}, {"Citation": "Yin D. F., Zhou X. J., Li N., Liu H. J., Yuan H. (2021). Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma. Bioengineered 12 (1), 1189\u20131201. 10.1080/21655979.2021.1909962", "ArticleIdList": ["10.1080/21655979.2021.1909962", "PMC8806201", "34969359"]}, {"Citation": "Yin X., Liao Y., Xiong W., Zhang Y., Zhou Y., Yang Y. (2020). Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression. Clin. Exp. Pharmacol. Physiol. 47 (6), 1049\u20131057. 10.1111/1440-1681.13279", "ArticleIdList": ["10.1111/1440-1681.13279", "32173903"]}, {"Citation": "Yu B., Zhao J., Dong Y. (2021). Circ_0000527 promotes retinoblastoma progression through modulating miR-98-5p/XIAP pathway. Curr. Eye Res. 46 (9), 1414\u20131423. 10.1080/02713683.2021.1891255", "ArticleIdList": ["10.1080/02713683.2021.1891255", "33629639"]}, {"Citation": "Yuan X., Sun Z., Cui C. (2021). Knockdown of lncRNA HOTTIP inhibits retinoblastoma progression by modulating the miR-101-3p/STC1 Axis. Technol. Cancer Res. Treat. 20, 1533033821997831. 10.1177/1533033821997831", "ArticleIdList": ["10.1177/1533033821997831", "PMC8020084", "33784880"]}, {"Citation": "Yun M-S., Kim S-E., Jeon S. H., Lee J-S., Choi K-Y. (2005). Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J. Cell Sci. 118 (2), 313\u2013322. 10.1242/jcs.01601", "ArticleIdList": ["10.1242/jcs.01601", "15615777"]}, {"Citation": "Zehavi L., Schayek H., Jacob-Hirsch J., Sidi Y., Leibowitz-Amit R., Avni D. (2015). MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma. Mol. Cancer 14, 68. 10.1186/s12943-015-0338-9", "ArticleIdList": ["10.1186/s12943-015-0338-9", "PMC4392476", "25889255"]}, {"Citation": "Zeng Z., Li Y., Pan Y., Lan X., Song F., Sun J., et al. (2018). Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat. Commun. 9 (1), 5395\u20135414. 10.1038/s41467-018-07810-w", "ArticleIdList": ["10.1038/s41467-018-07810-w", "PMC6300604", "30568162"]}, {"Citation": "Zhang A., Shang W., Nie Q., Li T., Li S. (2018). Long non-coding RNA H19 suppresses retinoblastoma progression via counteracting miR-17-92 cluster. J. Cell. Biochem. 119 (4), 3497\u20133509. 10.1002/jcb.26521", "ArticleIdList": ["10.1002/jcb.26521", "29143996"]}, {"Citation": "Zhang B., Wang Q., Pan X. (2007). MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiol. 210 (2), 279\u2013289. 10.1002/jcp.20869", "ArticleIdList": ["10.1002/jcp.20869", "17096367"]}, {"Citation": "Zhang C., Wu S. (2020). microRNA -378a-3p restrains the proliferation of retinoblastoma cells but promotes apoptosis of retinoblastoma cells via inhibition of FOXG1. Invest. Ophthalmol. Vis. Sci. 61 (5), 31. 10.1167/iovs.61.5.31", "ArticleIdList": ["10.1167/iovs.61.5.31", "PMC7405766", "32428232"]}, {"Citation": "Zhang G., Yang W., Li D., Li X., Huang J., Huang R., et al. (2020). lncRNA FEZF1-AS1 promotes migration, invasion and epithelial-mesenchymal transition of retinoblastoma cells by targeting miR-1236-3p. Mol. Med. Rep. 22 (5), 3635\u20133644. 10.3892/mmr.2020.11478", "ArticleIdList": ["10.3892/mmr.2020.11478", "PMC7533456", "32901841"]}, {"Citation": "Zhang H., Qiu X., Song Z., Lan L., Ren X., Ye B. (2022). CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis. Anticancer. Drugs 33 (1), e218\u2013e227. 10.1097/CAD.0000000000001190", "ArticleIdList": ["10.1097/CAD.0000000000001190", "34387590"]}, {"Citation": "Zhang H., Yang X., Xu Y., Li H. (2021). KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis. Biosci. Rep. 41 (1), BSR20201626. 10.1042/BSR20201626", "ArticleIdList": ["10.1042/BSR20201626", "PMC7805023", "33345272"]}, {"Citation": "Zhang H., Zhong J., Bian Z., Fang X., Peng Y., Hu Y. (2017). Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p. Biomed. Pharmacother. 87, 683\u2013691. 10.1016/j.biopha.2017.01.004", "ArticleIdList": ["10.1016/j.biopha.2017.01.004", "28088735"]}, {"Citation": "Zhang J., He J., Zhang L. (2018). The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling. Biomed. Pharmacother. 106, 35\u201342. 10.1016/j.biopha.2018.06.099", "ArticleIdList": ["10.1016/j.biopha.2018.06.099", "29945115"]}, {"Citation": "Zhang J., Knight R., Wang Y., Sawyer T. W., Martyniuk C. J., Langlois V. S. (2019). Hair follicle miRNAs: A novel biomarker for primary blast induced-mild traumatic brain injury. Biomarkers 24 (2), 166\u2013179. 10.1080/1354750X.2018.1531929", "ArticleIdList": ["10.1080/1354750X.2018.1531929", "30280938"]}, {"Citation": "Zhang L. J., Wang F., Qi P. Y., Zhou W. Y., Wang B. (2021). miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1. Open Med. 16 (1), 1364\u20131371. 10.1515/med-2021-0343", "ArticleIdList": ["10.1515/med-2021-0343", "PMC8435558", "34589612"]}, {"Citation": "Zhang M., Li Q., Pan Y., Wang H., Liu G., Yin H. (2018). MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways. Oncol. Rep. 39 (4), 2040\u20132050. 10.3892/or.2018.6264", "ArticleIdList": ["10.3892/or.2018.6264", "29436689"]}, {"Citation": "Zhang P., Lu Y., Liu X. Y., Zhou Y. H. (2015). Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells. Tumour Biol. 36 (1), 421\u2013428. 10.1007/s13277-014-2673-7", "ArticleIdList": ["10.1007/s13277-014-2673-7", "25266804"]}, {"Citation": "Zhang Q., Yu L., Qin D., Huang R., Jiang X., Zou C., et al. (2015). Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One 10 (3), e0120698. 10.1371/journal.pone.0120698", "ArticleIdList": ["10.1371/journal.pone.0120698", "PMC4370757", "25799050"]}, {"Citation": "Zhang S., Long J., Hu Y. (2020). Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. Biochem. Biophys. Res. Commun. 526 (2), 396\u2013403. 10.1016/j.bbrc.2020.03.083", "ArticleIdList": ["10.1016/j.bbrc.2020.03.083", "32223925"]}, {"Citation": "Zhang T., Yang J., Gong F., Li L., Li A. (2020). Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Cell cycleGeorget. Tex) 19 (18), 2270\u20132280. 10.1080/15384101.2020.1802813", "ArticleIdList": ["10.1080/15384101.2020.1802813", "PMC7513844", "32772636"]}, {"Citation": "Zhang W., Levi L., Banerjee P., Jain M., Noy N. (2015). Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling. Oncotarget 6 (34), 35830\u201335842. 10.18632/oncotarget.5767", "ArticleIdList": ["10.18632/oncotarget.5767", "PMC4742144", "26416422"]}, {"Citation": "Zhang X., Song L., Huang Y., Han S., Hou M., Li H. (2020). Downregulation of MST4 underlies a novel inhibitory role of MicroRNA let-7a in the progression of retinoblastoma. Invest. Ophthalmol. Vis. Sci. 61 (6), 28. 10.1167/iovs.61.6.28", "ArticleIdList": ["10.1167/iovs.61.6.28", "PMC7415300", "32539131"]}, {"Citation": "Zhang Y., Dou X., Kong Q., Li Y., Zhou X. (2022). Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression. Int. Ophthalmol. 42 (2), 509\u2013523. 10.1007/s10792-021-02067-7", "ArticleIdList": ["10.1007/s10792-021-02067-7", "34633608"]}, {"Citation": "Zhang Y., Wang X., Zhao Y. (2018). MicroRNA-874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin. Mol. Med. Rep. 18 (3), 3099\u20133105. 10.3892/mmr.2018.9295", "ArticleIdList": ["10.3892/mmr.2018.9295", "30015932"]}, {"Citation": "Zhang Y., Wu D., Xia F., Xian H., Zhu X., Cui H., et al. (2016). Downregulation of HDAC9 inhibits cell proliferation and tumor formation by inducing cell cycle arrest in retinoblastoma. Biochem. Biophys. Res. Commun. 473 (2), 600\u2013606. 10.1016/j.bbrc.2016.03.129", "ArticleIdList": ["10.1016/j.bbrc.2016.03.129", "27033599"]}, {"Citation": "Zhang Y., Wu J. H., Han F., Huang J. M., Shi S. Y., Gu R. D., et al. (2013). Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a. Neoplasma 60 (3), 247\u2013253. 10.4149/neo_2013_033", "ArticleIdList": ["10.4149/neo_2013_033", "23373993"]}, {"Citation": "Zhang Y., Xue C., Zhu X., Zhu X., Xian H., Huang Z. (2016). Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation. Cell. Signal. 28 (8), 850\u2013860. 10.1016/j.cellsig.2016.04.002", "ArticleIdList": ["10.1016/j.cellsig.2016.04.002", "27094723"]}, {"Citation": "Zhang Y., Zheng A. (2021). MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN. J. Biochem. 170 (2), 195\u2013202. 10.1093/jb/mvaa121", "ArticleIdList": ["10.1093/jb/mvaa121", "34562091"]}, {"Citation": "Zhang Y., Zhu X., Zhu X., Wu Y., Liu Y., Yao B., et al. (2017). MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5. Tumour Biol. 39 (3), 1010428317691674. 10.1177/1010428317691674", "ArticleIdList": ["10.1177/1010428317691674", "28351331"]}, {"Citation": "Zhao H., Wan J., Zhu Y. (2020). Carboplatin inhibits the progression of retinoblastoma through IncRNA XIST/miR-200a-3p/NRP1 Axis. Drug Des. devel. Ther. 14, 3417\u20133427. 10.2147/DDDT.S256813", "ArticleIdList": ["10.2147/DDDT.S256813", "PMC7457582", "32904674"]}, {"Citation": "Zhao W., An Y., Liang Y., Xie X. (2014). Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur. Rev. Med. Pharmacol. Sci. 18 (13), 1930\u20131936.", "ArticleIdList": ["25010625"]}, {"Citation": "Zhao W., Wang S., Qin T., Wang W. (2020). Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3. J. Cell. Biochem. 121 (7), 3516\u20133525. 10.1002/jcb.29631", "ArticleIdList": ["10.1002/jcb.29631", "32065448"]}, {"Citation": "Zhao Y., Zhang S., Zhang Y. (2017). MicroRNA-320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1. Mol. Med. Rep. 16 (2), 2191\u20132198. 10.3892/mmr.2017.6767", "ArticleIdList": ["10.3892/mmr.2017.6767", "28627594"]}, {"Citation": "Zhao Z., Liu W., Liu J., Wang J., Luo B. (2017). The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. J. Med. Virol. 89 (10), 1844\u20131851. 10.1002/jmv.24863", "ArticleIdList": ["10.1002/jmv.24863", "28543390"]}, {"Citation": "Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., et al. (2020). microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics 75, e1804. 10.6061/clinics/2020/e1804", "ArticleIdList": ["10.6061/clinics/2020/e1804", "PMC7426600", "32844953"]}, {"Citation": "Zheng T., Chen W., Wang X., Cai W., Wu F., Lin C. (2021). Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Exp. Eye Res. 211, 108650. 10.1016/j.exer.2021.108650", "ArticleIdList": ["10.1016/j.exer.2021.108650", "34102206"]}, {"Citation": "Zhong W., Yang J., Li M., Li L., Li A. (2019). Long noncoding RNA NEAT1 promotes the growth of human retinoblastoma cells via regulation of miR-204/CXCR4 axis. J. Cell. Physiol. 234 (7), 11567\u201311576. 10.1002/jcp.27812", "ArticleIdList": ["10.1002/jcp.27812", "30479013"]}, {"Citation": "Zhou Y., Li Z., Ding Y., Zhang P., Wang J., Zhang J., et al. (2018). Promoter methylation of WNT inhibitory factor-1 may be associated with the pathogenesis of multiple human tumors. J. Cancer Res. Ther. 14 (9), S381. 10.4103/0973-1482.235357", "ArticleIdList": ["10.4103/0973-1482.235357", "29970693"]}, {"Citation": "Zhu Y., Hao F. (2021). Knockdown of long non-coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR-3619-5p to target HDAC9. Int. J. Mol. Med. 47 (5), 74. 10.3892/ijmm.2021.4907", "ArticleIdList": ["10.3892/ijmm.2021.4907", "33693951"]}, {"Citation": "Zou J. Y., Crews F. T. (2014). Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling. PloS one 9 (2), e87915. 10.1371/journal.pone.0087915", "ArticleIdList": ["10.1371/journal.pone.0087915", "PMC3925099", "24551070"]}, {"Citation": "Zuo X., Fu C., Xie J., Wang X., Yan Z. (2022). Hsa_circ_0000527 downregulation suppresses the development of retinoblastoma by modulating the miR-27a-3p/HDAC9 pathway. Curr. Eye Res. 47 (1), 115\u2013126. 10.1080/02713683.2021.1925697", "ArticleIdList": ["10.1080/02713683.2021.1925697", "34823425"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "10"}, {"Year": "2022", "Month": "12", "Day": "5"}, {"Year": "2023", "Month": "1", "Day": "9", "Hour": "4", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36619866", "PMC9816416", "10.3389/fcell.2022.1065837", "1065837"]}}], "PubmedBookArticle": []}